This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-let-7f-1-3p | APC | 1.29 | 0 | -0.24 | 0.1992 | mirMAP | -0.12 | 0.01395 | NA | |
2 | hsa-miR-106b-5p | APC | 1.71 | 0 | -0.24 | 0.1992 | miRNAWalker2 validate; miRTarBase | -0.14 | 0.00091 | 23087084 | miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells |
3 | hsa-miR-107 | APC | 0.9 | 5.0E-5 | -0.24 | 0.1992 | miRanda | -0.16 | 0.00649 | NA | |
4 | hsa-miR-186-5p | APC | 0.15 | 0.43471 | -0.24 | 0.1992 | miRNAWalker2 validate | -0.18 | 0.01258 | NA | |
5 | hsa-miR-320a | APC | 0.59 | 0.0119 | -0.24 | 0.1992 | miRanda | -0.11 | 0.04249 | NA | |
6 | hsa-miR-320b | APC | 1.11 | 0.0005 | -0.24 | 0.1992 | miRanda | -0.16 | 9.0E-5 | NA | |
7 | hsa-miR-330-3p | APC | 0.8 | 0.00747 | -0.24 | 0.1992 | PITA; mirMAP | -0.11 | 0.01396 | NA | |
8 | hsa-miR-374b-5p | APC | -0.19 | 0.3948 | -0.24 | 0.1992 | mirMAP | -0.15 | 0.0157 | NA | |
9 | hsa-miR-590-3p | APC | 1.12 | 0.00016 | -0.24 | 0.1992 | PITA; miRanda; mirMAP; miRNATAP | -0.1 | 0.019 | NA | |
10 | hsa-miR-185-5p | APC2 | 1.14 | 0 | -1.51 | 0.00013 | miRNATAP | -0.33 | 0.02085 | NA | |
11 | hsa-miR-20a-3p | APC2 | 1.14 | 0.00045 | -1.51 | 0.00013 | mirMAP | -0.27 | 0.0021 | NA | |
12 | hsa-miR-2110 | APC2 | 0.76 | 0.0724 | -1.51 | 0.00013 | MirTarget; miRNATAP | -0.15 | 0.03009 | NA | |
13 | hsa-miR-221-5p | APC2 | 1.89 | 0 | -1.51 | 0.00013 | mirMAP | -0.34 | 4.0E-5 | NA | |
14 | hsa-miR-345-5p | APC2 | 1.84 | 0 | -1.51 | 0.00013 | mirMAP | -0.29 | 0.00069 | NA | |
15 | hsa-miR-361-3p | APC2 | -0.13 | 0.56605 | -1.51 | 0.00013 | mirMAP | -0.33 | 0.01169 | NA | |
16 | hsa-miR-3934-5p | APC2 | 0.86 | 0.0209 | -1.51 | 0.00013 | mirMAP | -0.16 | 0.03755 | NA | |
17 | hsa-miR-625-5p | APC2 | 0.54 | 0.2038 | -1.51 | 0.00013 | mirMAP | -0.31 | 0 | NA | |
18 | hsa-let-7a-3p | AXIN2 | 0.5 | 0.04111 | -0.66 | 0.25177 | miRNATAP | -0.39 | 0.01986 | NA | |
19 | hsa-miR-16-2-3p | AXIN2 | 1.8 | 0 | -0.66 | 0.25177 | mirMAP | -0.28 | 0.02871 | NA | |
20 | hsa-miR-205-5p | AXIN2 | 3.14 | 0.02932 | -0.66 | 0.25177 | miRNATAP | -0.17 | 0 | NA | |
21 | hsa-miR-34c-5p | AXIN2 | 2.21 | 0.00038 | -0.66 | 0.25177 | miRanda | -0.21 | 0.00103 | NA | |
22 | hsa-miR-424-5p | AXIN2 | 1.09 | 0.00042 | -0.66 | 0.25177 | MirTarget; miRNATAP | -0.32 | 0.01687 | NA | |
23 | hsa-miR-944 | AXIN2 | 3.33 | 0.01778 | -0.66 | 0.25177 | MirTarget; PITA; miRNATAP | -0.2 | 0 | NA | |
24 | hsa-miR-103a-3p | BTRC | 0.84 | 0 | -0.39 | 0.00796 | MirTarget; miRNATAP | -0.19 | 0.00257 | NA | |
25 | hsa-miR-107 | BTRC | 0.9 | 5.0E-5 | -0.39 | 0.00796 | MirTarget; miRanda; miRNATAP | -0.11 | 0.01593 | NA | |
26 | hsa-miR-148b-5p | BTRC | 1.04 | 0.00196 | -0.39 | 0.00796 | mirMAP | -0.11 | 0.0005 | NA | |
27 | hsa-miR-15a-5p | BTRC | 1.04 | 0 | -0.39 | 0.00796 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0.00011 | NA | |
28 | hsa-miR-15b-5p | BTRC | 1.62 | 0 | -0.39 | 0.00796 | MirTarget; miRNATAP | -0.11 | 0.00209 | NA | |
29 | hsa-miR-16-1-3p | BTRC | 1.43 | 0 | -0.39 | 0.00796 | mirMAP | -0.1 | 0.00835 | NA | |
30 | hsa-miR-16-5p | BTRC | 1.01 | 1.0E-5 | -0.39 | 0.00796 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.15 | 0.00163 | NA | |
31 | hsa-miR-185-5p | BTRC | 1.14 | 0 | -0.39 | 0.00796 | mirMAP | -0.12 | 0.01836 | NA | |
32 | hsa-miR-186-5p | BTRC | 0.15 | 0.43471 | -0.39 | 0.00796 | mirMAP | -0.13 | 0.01634 | NA | |
33 | hsa-miR-320a | BTRC | 0.59 | 0.0119 | -0.39 | 0.00796 | miRNAWalker2 validate; PITA | -0.16 | 0.00028 | NA | |
34 | hsa-miR-320b | BTRC | 1.11 | 0.0005 | -0.39 | 0.00796 | PITA | -0.11 | 0.00036 | NA | |
35 | hsa-miR-454-3p | BTRC | 0.63 | 0.01349 | -0.39 | 0.00796 | mirMAP | -0.19 | 0 | NA | |
36 | hsa-miR-505-3p | BTRC | 0.83 | 0.00112 | -0.39 | 0.00796 | MirTarget | -0.12 | 0.00372 | NA | |
37 | hsa-miR-195-3p | CACYBP | -1.35 | 2.0E-5 | 0.91 | 0 | mirMAP | -0.2 | 0 | NA | |
38 | hsa-miR-30a-3p | CACYBP | -1.73 | 0 | 0.91 | 0 | MirTarget | -0.16 | 2.0E-5 | NA | |
39 | hsa-miR-30e-3p | CACYBP | -0.91 | 1.0E-5 | 0.91 | 0 | MirTarget | -0.16 | 0.01742 | NA | |
40 | hsa-miR-130b-5p | CAMK2A | 0.7 | 0.05101 | -0.13 | 0.82753 | mirMAP | -0.37 | 0.00178 | NA | |
41 | hsa-miR-142-5p | CAMK2A | 1.56 | 1.0E-5 | -0.13 | 0.82753 | PITA; miRNATAP | -0.46 | 0.00015 | NA | |
42 | hsa-miR-144-3p | CAMK2A | -0.13 | 0.79825 | -0.13 | 0.82753 | mirMAP | -0.3 | 0.00022 | NA | |
43 | hsa-miR-148a-3p | CAMK2A | -1.54 | 4.0E-5 | -0.13 | 0.82753 | miRNATAP | -0.32 | 0.00397 | NA | |
44 | hsa-miR-148b-5p | CAMK2A | 1.04 | 0.00196 | -0.13 | 0.82753 | mirMAP | -0.38 | 0.00256 | NA | |
45 | hsa-miR-15b-3p | CAMK2A | 1.76 | 0 | -0.13 | 0.82753 | mirMAP | -0.51 | 9.0E-5 | NA | |
46 | hsa-miR-185-5p | CAMK2A | 1.14 | 0 | -0.13 | 0.82753 | mirMAP | -0.49 | 0.01873 | NA | |
47 | hsa-miR-19b-1-5p | CAMK2A | 1.39 | 0 | -0.13 | 0.82753 | mirMAP | -0.61 | 2.0E-5 | NA | |
48 | hsa-miR-25-3p | CAMK2A | 1.01 | 0.00042 | -0.13 | 0.82753 | MirTarget | -0.53 | 0.00031 | NA | |
49 | hsa-miR-26a-5p | CAMK2A | -0.38 | 0.04425 | -0.13 | 0.82753 | miRNATAP | -0.94 | 3.0E-5 | NA | |
50 | hsa-miR-26b-5p | CAMK2A | -0.3 | 0.16008 | -0.13 | 0.82753 | miRNATAP | -1.07 | 0 | NA | |
51 | hsa-miR-30b-5p | CAMK2A | -0.43 | 0.05936 | -0.13 | 0.82753 | mirMAP | -0.87 | 0 | NA | |
52 | hsa-miR-30c-5p | CAMK2A | -0.98 | 5.0E-5 | -0.13 | 0.82753 | mirMAP | -0.37 | 0.03689 | NA | |
53 | hsa-miR-30d-5p | CAMK2A | -0.55 | 0.01401 | -0.13 | 0.82753 | mirMAP | -0.95 | 0 | NA | |
54 | hsa-miR-30e-5p | CAMK2A | -0.57 | 0.01125 | -0.13 | 0.82753 | mirMAP | -0.64 | 0.0008 | NA | |
55 | hsa-miR-32-5p | CAMK2A | 0.42 | 0.10646 | -0.13 | 0.82753 | MirTarget | -0.95 | 0 | NA | |
56 | hsa-miR-320c | CAMK2A | 0.46 | 0.24061 | -0.13 | 0.82753 | mirMAP | -0.54 | 2.0E-5 | NA | |
57 | hsa-miR-331-3p | CAMK2A | 1.05 | 0.0001 | -0.13 | 0.82753 | MirTarget | -0.39 | 0.01225 | NA | |
58 | hsa-miR-335-5p | CAMK2A | 1.6 | 6.0E-5 | -0.13 | 0.82753 | mirMAP | -0.61 | 0 | NA | |
59 | hsa-miR-338-3p | CAMK2A | -0.96 | 0.01915 | -0.13 | 0.82753 | miRNATAP | -0.3 | 0.00432 | NA | |
60 | hsa-miR-361-3p | CAMK2A | -0.13 | 0.56605 | -0.13 | 0.82753 | mirMAP | -0.64 | 0.00126 | NA | |
61 | hsa-miR-3614-5p | CAMK2A | 1.1 | 0.00706 | -0.13 | 0.82753 | mirMAP | -0.43 | 3.0E-5 | NA | |
62 | hsa-miR-363-3p | CAMK2A | -1.17 | 0.01565 | -0.13 | 0.82753 | MirTarget | -0.29 | 0.0011 | NA | |
63 | hsa-miR-429 | CAMK2A | 1.4 | 0.009 | -0.13 | 0.82753 | miRNATAP | -0.27 | 0.0005 | NA | |
64 | hsa-miR-616-5p | CAMK2A | 0.83 | 0.03478 | -0.13 | 0.82753 | mirMAP | -0.32 | 0.00341 | NA | |
65 | hsa-miR-625-5p | CAMK2A | 0.54 | 0.2038 | -0.13 | 0.82753 | mirMAP | -0.51 | 0 | NA | |
66 | hsa-miR-7-1-3p | CAMK2A | 0.71 | 0.04123 | -0.13 | 0.82753 | MirTarget | -0.6 | 0 | NA | |
67 | hsa-miR-92a-3p | CAMK2A | 1.22 | 1.0E-5 | -0.13 | 0.82753 | MirTarget | -0.69 | 1.0E-5 | NA | |
68 | hsa-miR-939-5p | CAMK2A | 0.86 | 0.01248 | -0.13 | 0.82753 | MirTarget | -0.31 | 0.02432 | NA | |
69 | hsa-miR-10a-5p | CAMK2B | -0.47 | 0.1488 | -2.37 | 0.00126 | miRNATAP | -0.4 | 0.01403 | NA | |
70 | hsa-miR-29a-3p | CAMK2B | -0.11 | 0.61501 | -2.37 | 0.00126 | mirMAP | -0.76 | 0.00147 | NA | |
71 | hsa-miR-34a-5p | CAMK2B | 0.79 | 0.00024 | -2.37 | 0.00126 | mirMAP | -0.5 | 0.04197 | NA | |
72 | hsa-miR-362-3p | CAMK2B | -0.03 | 0.91378 | -2.37 | 0.00126 | miRanda | -0.38 | 0.02315 | NA | |
73 | hsa-miR-625-5p | CAMK2B | 0.54 | 0.2038 | -2.37 | 0.00126 | mirMAP | -0.64 | 0 | NA | |
74 | hsa-miR-17-3p | CAMK2D | 1.31 | 0 | -0.67 | 0.00279 | miRNATAP | -0.13 | 0.03195 | NA | |
75 | hsa-miR-185-5p | CAMK2D | 1.14 | 0 | -0.67 | 0.00279 | miRNATAP | -0.2 | 0.0118 | NA | |
76 | hsa-miR-197-3p | CAMK2D | 0.89 | 0.0002 | -0.67 | 0.00279 | miRNATAP | -0.18 | 0.00721 | NA | |
77 | hsa-miR-320b | CAMK2D | 1.11 | 0.0005 | -0.67 | 0.00279 | miRanda | -0.11 | 0.03119 | NA | |
78 | hsa-miR-421 | CAMK2D | 1.81 | 0 | -0.67 | 0.00279 | miRNATAP | -0.15 | 0.00111 | NA | |
79 | hsa-miR-127-5p | CAMK2G | 0.68 | 0.02163 | -0.26 | 0.15921 | MirTarget; PITA; miRNATAP | -0.14 | 0.0014 | NA | |
80 | hsa-miR-16-2-3p | CAMK2G | 1.8 | 0 | -0.26 | 0.15921 | mirMAP | -0.15 | 0.00029 | NA | |
81 | hsa-miR-16-5p | CAMK2G | 1.01 | 1.0E-5 | -0.26 | 0.15921 | miRNAWalker2 validate | -0.18 | 0.00182 | NA | |
82 | hsa-miR-1976 | CAMK2G | 0.92 | 0.00012 | -0.26 | 0.15921 | MirTarget | -0.18 | 0.00078 | NA | |
83 | hsa-miR-484 | CAMK2G | 0.71 | 0.00234 | -0.26 | 0.15921 | mirMAP | -0.16 | 0.00418 | NA | |
84 | hsa-miR-590-3p | CAMK2G | 1.12 | 0.00016 | -0.26 | 0.15921 | miRanda | -0.17 | 0.00013 | NA | |
85 | hsa-let-7f-5p | CCND1 | 0.63 | 0.0345 | 0.62 | 0.1312 | miRNAWalker2 validate; miRNATAP | -0.22 | 0.02412 | NA | |
86 | hsa-let-7g-5p | CCND1 | 0.33 | 0.24114 | 0.62 | 0.1312 | miRNATAP | -0.24 | 0.02643 | NA | |
87 | hsa-miR-29b-3p | CCND1 | -0.23 | 0.36746 | 0.62 | 0.1312 | mirMAP | -0.25 | 0.03052 | NA | |
88 | hsa-miR-29c-3p | CCND1 | -1.62 | 0 | 0.62 | 0.1312 | mirMAP | -0.21 | 0.01798 | NA | |
89 | hsa-miR-338-3p | CCND1 | -0.96 | 0.01915 | 0.62 | 0.1312 | miRNAWalker2 validate; miRTarBase; miRanda | -0.24 | 0.00086 | NA | |
90 | hsa-miR-7-1-3p | CCND1 | 0.71 | 0.04123 | 0.62 | 0.1312 | mirMAP | -0.17 | 0.04041 | NA | |
91 | hsa-let-7a-3p | CCND2 | 0.5 | 0.04111 | -0.5 | 0.3 | mirMAP | -0.54 | 0.0001 | 20418948 | MicroRNA let 7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2 |
92 | hsa-let-7b-3p | CCND2 | 0.22 | 0.29604 | -0.5 | 0.3 | mirMAP | -0.46 | 0.00588 | NA | |
93 | hsa-let-7b-5p | CCND2 | 0.06 | 0.7814 | -0.5 | 0.3 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.41 | 0.01341 | NA | |
94 | hsa-miR-106a-5p | CCND2 | -0.17 | 0.64287 | -0.5 | 0.3 | miRNATAP | -0.2 | 0.03301 | NA | |
95 | hsa-miR-106b-5p | CCND2 | 1.71 | 0 | -0.5 | 0.3 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.42 | 9.0E-5 | NA | |
96 | hsa-miR-130b-5p | CCND2 | 0.7 | 0.05101 | -0.5 | 0.3 | mirMAP | -0.39 | 2.0E-5 | NA | |
97 | hsa-miR-141-3p | CCND2 | 1.46 | 0.00116 | -0.5 | 0.3 | MirTarget; TargetScan | -0.21 | 0.00436 | NA | |
98 | hsa-miR-15b-5p | CCND2 | 1.62 | 0 | -0.5 | 0.3 | miRNATAP | -0.44 | 0.00021 | NA | |
99 | hsa-miR-16-2-3p | CCND2 | 1.8 | 0 | -0.5 | 0.3 | mirMAP | -0.55 | 0 | NA | |
100 | hsa-miR-16-5p | CCND2 | 1.01 | 1.0E-5 | -0.5 | 0.3 | miRNAWalker2 validate; miRNATAP | -0.67 | 1.0E-5 | NA | |
101 | hsa-miR-181a-2-3p | CCND2 | 0.9 | 0.00083 | -0.5 | 0.3 | mirMAP | -0.38 | 0.00236 | NA | |
102 | hsa-miR-182-5p | CCND2 | 0.89 | 0.03106 | -0.5 | 0.3 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.32 | 9.0E-5 | NA | |
103 | hsa-miR-183-5p | CCND2 | 1.66 | 0.00052 | -0.5 | 0.3 | miRNATAP | -0.29 | 2.0E-5 | NA | |
104 | hsa-miR-185-5p | CCND2 | 1.14 | 0 | -0.5 | 0.3 | MirTarget; miRNATAP | -0.39 | 0.02059 | NA | |
105 | hsa-miR-19a-3p | CCND2 | 1.27 | 0.00011 | -0.5 | 0.3 | MirTarget; miRNATAP | -0.25 | 0.01406 | NA | |
106 | hsa-miR-19b-3p | CCND2 | 0.76 | 0.00653 | -0.5 | 0.3 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.32 | 0.00853 | NA | |
107 | hsa-miR-200a-3p | CCND2 | 0.72 | 0.19391 | -0.5 | 0.3 | MirTarget | -0.16 | 0.01011 | NA | |
108 | hsa-miR-21-3p | CCND2 | 1.75 | 0 | -0.5 | 0.3 | mirMAP | -0.33 | 0.0051 | NA | |
109 | hsa-miR-224-3p | CCND2 | 1.52 | 0.0065 | -0.5 | 0.3 | mirMAP | -0.27 | 4.0E-5 | NA | |
110 | hsa-miR-26b-5p | CCND2 | -0.3 | 0.16008 | -0.5 | 0.3 | mirMAP; miRNATAP | -0.58 | 0.00034 | NA | |
111 | hsa-miR-301a-3p | CCND2 | 1.45 | 1.0E-5 | -0.5 | 0.3 | miRNAWalker2 validate | -0.38 | 0.0002 | NA | |
112 | hsa-miR-3065-3p | CCND2 | -1.04 | 0.02184 | -0.5 | 0.3 | MirTarget; miRNATAP | -0.2 | 0.00685 | NA | |
113 | hsa-miR-3065-5p | CCND2 | -0.24 | 0.63312 | -0.5 | 0.3 | mirMAP | -0.24 | 0.00057 | NA | |
114 | hsa-miR-32-3p | CCND2 | 0.58 | 0.11837 | -0.5 | 0.3 | mirMAP | -0.22 | 0.03694 | NA | |
115 | hsa-miR-320b | CCND2 | 1.11 | 0.0005 | -0.5 | 0.3 | mirMAP; miRNATAP | -0.22 | 0.0426 | NA | |
116 | hsa-miR-324-3p | CCND2 | 1.05 | 0.00039 | -0.5 | 0.3 | miRNAWalker2 validate | -0.28 | 0.01615 | NA | |
117 | hsa-miR-335-5p | CCND2 | 1.6 | 6.0E-5 | -0.5 | 0.3 | miRNAWalker2 validate | -0.18 | 0.0296 | NA | |
118 | hsa-miR-33a-3p | CCND2 | 0.35 | 0.32171 | -0.5 | 0.3 | MirTarget | -0.25 | 0.01611 | NA | |
119 | hsa-miR-424-5p | CCND2 | 1.09 | 0.00042 | -0.5 | 0.3 | miRNATAP | -0.39 | 0.0003 | NA | |
120 | hsa-miR-429 | CCND2 | 1.4 | 0.009 | -0.5 | 0.3 | miRNATAP | -0.19 | 0.002 | NA | |
121 | hsa-miR-450b-5p | CCND2 | 0.46 | 0.13274 | -0.5 | 0.3 | MirTarget; PITA; miRNATAP | -0.32 | 0.00413 | NA | |
122 | hsa-miR-590-3p | CCND2 | 1.12 | 0.00016 | -0.5 | 0.3 | miRanda; mirMAP | -0.33 | 0.00348 | NA | |
123 | hsa-miR-590-5p | CCND2 | 1.04 | 0.00027 | -0.5 | 0.3 | mirMAP | -0.41 | 0.00055 | NA | |
124 | hsa-miR-615-3p | CCND2 | 2.83 | 3.0E-5 | -0.5 | 0.3 | miRNAWalker2 validate | -0.14 | 0.03433 | NA | |
125 | hsa-miR-708-5p | CCND2 | 1.42 | 0.01096 | -0.5 | 0.3 | mirMAP | -0.12 | 0.04439 | NA | |
126 | hsa-miR-9-3p | CCND2 | 0.33 | 0.54111 | -0.5 | 0.3 | MirTarget; mirMAP; miRNATAP | -0.19 | 0.00361 | NA | |
127 | hsa-miR-93-5p | CCND2 | 1.75 | 0 | -0.5 | 0.3 | miRNATAP | -0.32 | 0.00244 | NA | |
128 | hsa-miR-96-5p | CCND2 | 1.14 | 0.00943 | -0.5 | 0.3 | TargetScan; miRNATAP | -0.33 | 3.0E-5 | NA | |
129 | hsa-miR-27b-3p | CCND3 | 0.08 | 0.72527 | 0.04 | 0.88352 | miRNAWalker2 validate | -0.18 | 0.0163 | NA | |
130 | hsa-miR-409-5p | CCND3 | 1.11 | 0.00089 | 0.04 | 0.88352 | miRNATAP | -0.12 | 0.0184 | NA | |
131 | hsa-miR-96-5p | CCND3 | 1.14 | 0.00943 | 0.04 | 0.88352 | TargetScan | -0.12 | 0.00328 | NA | |
132 | hsa-miR-140-5p | CHD8 | 0.21 | 0.303 | 0.08 | 0.52589 | miRanda | -0.16 | 0.0007 | NA | |
133 | hsa-miR-221-3p | CHD8 | 1.33 | 0 | 0.08 | 0.52589 | MirTarget; miRNATAP | -0.11 | 0.00136 | NA | |
134 | hsa-miR-222-3p | CHD8 | 1.39 | 0 | 0.08 | 0.52589 | MirTarget; miRNATAP | -0.11 | 0.00087 | NA | |
135 | hsa-miR-186-5p | CREBBP | 0.15 | 0.43471 | -0.11 | 0.45436 | mirMAP; miRNATAP | -0.14 | 0.00768 | NA | |
136 | hsa-miR-107 | CSNK1A1 | 0.9 | 5.0E-5 | -0.13 | 0.51313 | PITA; miRanda; miRNATAP | -0.29 | 0 | NA | |
137 | hsa-miR-126-5p | CSNK1A1 | 0.42 | 0.07532 | -0.13 | 0.51313 | mirMAP | -0.16 | 0.00576 | NA | |
138 | hsa-miR-148a-5p | CSNK1A1 | -0.69 | 0.0793 | -0.13 | 0.51313 | MirTarget | -0.16 | 0 | NA | |
139 | hsa-miR-186-5p | CSNK1A1 | 0.15 | 0.43471 | -0.13 | 0.51313 | miRNAWalker2 validate; miRNATAP | -0.27 | 0.00019 | NA | |
140 | hsa-miR-19a-3p | CSNK1A1 | 1.27 | 0.00011 | -0.13 | 0.51313 | mirMAP | -0.11 | 0.00763 | NA | |
141 | hsa-miR-19b-3p | CSNK1A1 | 0.76 | 0.00653 | -0.13 | 0.51313 | mirMAP | -0.12 | 0.01543 | NA | |
142 | hsa-miR-2110 | CSNK1A1 | 0.76 | 0.0724 | -0.13 | 0.51313 | miRNATAP | -0.14 | 1.0E-5 | NA | |
143 | hsa-miR-29a-5p | CSNK1A1 | 0.59 | 0.02301 | -0.13 | 0.51313 | mirMAP | -0.15 | 0.00587 | NA | |
144 | hsa-miR-30a-5p | CSNK1A1 | -1.72 | 0 | -0.13 | 0.51313 | MirTarget; miRNATAP | -0.11 | 0.00528 | NA | |
145 | hsa-miR-30b-5p | CSNK1A1 | -0.43 | 0.05936 | -0.13 | 0.51313 | MirTarget; mirMAP; miRNATAP | -0.25 | 2.0E-5 | NA | |
146 | hsa-miR-30c-5p | CSNK1A1 | -0.98 | 5.0E-5 | -0.13 | 0.51313 | MirTarget; mirMAP; miRNATAP | -0.18 | 0.00097 | NA | |
147 | hsa-miR-30d-5p | CSNK1A1 | -0.55 | 0.01401 | -0.13 | 0.51313 | MirTarget; miRNATAP | -0.25 | 3.0E-5 | NA | |
148 | hsa-miR-30e-5p | CSNK1A1 | -0.57 | 0.01125 | -0.13 | 0.51313 | MirTarget | -0.12 | 0.04316 | NA | |
149 | hsa-miR-320a | CSNK1A1 | 0.59 | 0.0119 | -0.13 | 0.51313 | mirMAP | -0.17 | 0.00251 | NA | |
150 | hsa-miR-320b | CSNK1A1 | 1.11 | 0.0005 | -0.13 | 0.51313 | mirMAP | -0.15 | 0.00043 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALING PATHWAY | 76 | 351 | 1.777e-105 | 8.27e-102 |
2 | CANONICAL WNT SIGNALING PATHWAY | 39 | 95 | 8.408e-64 | 1.956e-60 |
3 | REGULATION OF WNT SIGNALING PATHWAY | 47 | 310 | 3.254e-54 | 5.047e-51 |
4 | NON CANONICAL WNT SIGNALING PATHWAY | 36 | 140 | 4.886e-50 | 5.684e-47 |
5 | REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 34 | 236 | 6.795e-38 | 6.323e-35 |
6 | NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 31 | 197 | 9.493e-36 | 7.362e-33 |
7 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 64 | 1929 | 6.451e-34 | 4.288e-31 |
8 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 50 | 1021 | 2.883e-33 | 1.677e-30 |
9 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 59 | 1672 | 3.314e-32 | 1.713e-29 |
10 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 18 | 39 | 1.282e-30 | 5.964e-28 |
11 | POSITIVE REGULATION OF GENE EXPRESSION | 58 | 1733 | 2.469e-30 | 1.044e-27 |
12 | TISSUE DEVELOPMENT | 53 | 1518 | 3.291e-28 | 1.276e-25 |
13 | EPITHELIUM DEVELOPMENT | 44 | 945 | 5.101e-28 | 1.709e-25 |
14 | POSITIVE REGULATION OF CELL COMMUNICATION | 53 | 1532 | 5.141e-28 | 1.709e-25 |
15 | REGULATION OF CELL DIFFERENTIATION | 52 | 1492 | 1.443e-27 | 4.198e-25 |
16 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 52 | 1492 | 1.443e-27 | 4.198e-25 |
17 | MORPHOGENESIS OF AN EPITHELIUM | 32 | 400 | 2.573e-27 | 7.043e-25 |
18 | NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 24 | 162 | 4.96e-27 | 1.282e-24 |
19 | TISSUE MORPHOGENESIS | 35 | 533 | 5.39e-27 | 1.32e-24 |
20 | REGULATION OF ORGAN MORPHOGENESIS | 27 | 242 | 6.102e-27 | 1.42e-24 |
21 | REGULATION OF PROTEIN MODIFICATION PROCESS | 54 | 1710 | 1.135e-26 | 2.514e-24 |
22 | TUBE MORPHOGENESIS | 29 | 323 | 3.547e-26 | 7.502e-24 |
23 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 54 | 1805 | 1.579e-25 | 3.194e-23 |
24 | TUBE DEVELOPMENT | 34 | 552 | 2.725e-25 | 5.284e-23 |
25 | NEGATIVE REGULATION OF CELL COMMUNICATION | 45 | 1192 | 6.76e-25 | 1.258e-22 |
26 | ORGAN MORPHOGENESIS | 39 | 841 | 1.402e-24 | 2.508e-22 |
27 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 47 | 1360 | 1.84e-24 | 3.171e-22 |
28 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 50 | 1618 | 5.219e-24 | 8.672e-22 |
29 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 51 | 1791 | 6.166e-23 | 9.894e-21 |
30 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 19 | 110 | 7.187e-23 | 1.115e-20 |
31 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 42 | 1142 | 1.124e-22 | 1.688e-20 |
32 | EMBRYO DEVELOPMENT | 38 | 894 | 1.388e-22 | 2.019e-20 |
33 | EMBRYONIC MORPHOGENESIS | 31 | 539 | 3.835e-22 | 5.407e-20 |
34 | NEUROGENESIS | 45 | 1402 | 5.061e-22 | 6.927e-20 |
35 | NEURON DIFFERENTIATION | 37 | 874 | 6.632e-22 | 8.817e-20 |
36 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 41 | 1135 | 8.255e-22 | 1.067e-19 |
37 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 36 | 823 | 9.171e-22 | 1.153e-19 |
38 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 35 | 788 | 2.345e-21 | 2.798e-19 |
39 | CIRCULATORY SYSTEM DEVELOPMENT | 35 | 788 | 2.345e-21 | 2.798e-19 |
40 | INTRACELLULAR SIGNAL TRANSDUCTION | 46 | 1572 | 6.474e-21 | 7.531e-19 |
41 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 30 | 554 | 1.113e-20 | 1.256e-18 |
42 | CELL FATE COMMITMENT | 22 | 227 | 1.134e-20 | 1.256e-18 |
43 | PATTERN SPECIFICATION PROCESS | 27 | 418 | 1.353e-20 | 1.464e-18 |
44 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 48 | 1784 | 2.188e-20 | 2.313e-18 |
45 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 38 | 1036 | 2.335e-20 | 2.362e-18 |
46 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 38 | 1036 | 2.335e-20 | 2.362e-18 |
47 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 43 | 1395 | 2.728e-20 | 2.701e-18 |
48 | REGULATION OF CELL CYCLE | 36 | 949 | 1.01e-19 | 9.789e-18 |
49 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 39 | 1152 | 1.069e-19 | 1.015e-17 |
50 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 36 | 957 | 1.328e-19 | 1.236e-17 |
51 | REGULATION OF CELL DEATH | 43 | 1472 | 2.094e-19 | 1.873e-17 |
52 | REGULATION OF EMBRYONIC DEVELOPMENT | 17 | 114 | 2.07e-19 | 1.873e-17 |
53 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 45 | 1656 | 3.761e-19 | 3.302e-17 |
54 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 47 | 1848 | 6.407e-19 | 5.363e-17 |
55 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 36 | 1004 | 6.311e-19 | 5.363e-17 |
56 | REGIONALIZATION | 23 | 311 | 6.454e-19 | 5.363e-17 |
57 | POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 18 | 152 | 1.226e-18 | 1.001e-16 |
58 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 24 | 365 | 1.576e-18 | 1.265e-16 |
59 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 23 | 337 | 3.87e-18 | 3.001e-16 |
60 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 32 | 801 | 3.846e-18 | 3.001e-16 |
61 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 27 | 552 | 1.658e-17 | 1.265e-15 |
62 | BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY | 10 | 22 | 2.302e-17 | 1.719e-15 |
63 | REGULATION OF BINDING | 21 | 283 | 2.328e-17 | 1.719e-15 |
64 | CELL DEVELOPMENT | 40 | 1426 | 2.381e-17 | 1.731e-15 |
65 | CELL PROLIFERATION | 29 | 672 | 2.499e-17 | 1.789e-15 |
66 | REGULATION OF CELLULAR RESPONSE TO STRESS | 29 | 691 | 5.24e-17 | 3.694e-15 |
67 | REGULATION OF RESPONSE TO STRESS | 40 | 1468 | 6.494e-17 | 4.51e-15 |
68 | CELLULAR RESPONSE TO RETINOIC ACID | 13 | 65 | 7.57e-17 | 5.18e-15 |
69 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 18 | 194 | 1.022e-16 | 6.892e-15 |
70 | REGULATION OF CELL PROLIFERATION | 40 | 1496 | 1.244e-16 | 8.267e-15 |
71 | SENSORY ORGAN DEVELOPMENT | 25 | 493 | 1.323e-16 | 8.672e-15 |
72 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 21 | 323 | 3.405e-16 | 2.2e-14 |
73 | HEART DEVELOPMENT | 24 | 466 | 4.111e-16 | 2.621e-14 |
74 | PROTEIN PHOSPHORYLATION | 32 | 944 | 4.331e-16 | 2.723e-14 |
75 | REGULATION OF PROTEIN LOCALIZATION | 32 | 950 | 5.184e-16 | 3.216e-14 |
76 | NEURAL TUBE DEVELOPMENT | 16 | 149 | 5.533e-16 | 3.387e-14 |
77 | REGULATION OF KINASE ACTIVITY | 29 | 776 | 1.104e-15 | 6.585e-14 |
78 | DORSAL VENTRAL AXIS SPECIFICATION | 9 | 20 | 1.092e-15 | 6.585e-14 |
79 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 39 | 1518 | 1.285e-15 | 7.569e-14 |
80 | REGULATION OF CELL MORPHOGENESIS | 25 | 552 | 1.818e-15 | 1.057e-13 |
81 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 15 | 134 | 2.534e-15 | 1.456e-13 |
82 | REGULATION OF TRANSFERASE ACTIVITY | 31 | 946 | 3.489e-15 | 1.963e-13 |
83 | CELL ACTIVATION | 25 | 568 | 3.502e-15 | 1.963e-13 |
84 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 15 | 142 | 6.098e-15 | 3.378e-13 |
85 | REGULATION OF CELL DEVELOPMENT | 29 | 836 | 7.585e-15 | 4.152e-13 |
86 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 21 | 381 | 9.19e-15 | 4.972e-13 |
87 | POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 14 | 119 | 1.115e-14 | 5.962e-13 |
88 | POSITIVE REGULATION OF CELL DEATH | 25 | 605 | 1.477e-14 | 7.81e-13 |
89 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 17 | 220 | 1.644e-14 | 8.597e-13 |
90 | REGULATION OF CELL CYCLE PROCESS | 24 | 558 | 2.235e-14 | 1.155e-12 |
91 | REGULATION OF PROTEIN TARGETING | 19 | 307 | 2.426e-14 | 1.24e-12 |
92 | REGULATION OF JNK CASCADE | 15 | 159 | 3.329e-14 | 1.684e-12 |
93 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 23 | 513 | 3.488e-14 | 1.727e-12 |
94 | SOMITE DEVELOPMENT | 12 | 78 | 3.486e-14 | 1.727e-12 |
95 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 37 | 1517 | 4.407e-14 | 2.136e-12 |
96 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 15 | 162 | 4.399e-14 | 2.136e-12 |
97 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 16 | 197 | 4.703e-14 | 2.256e-12 |
98 | REGULATION OF CELLULAR LOCALIZATION | 34 | 1277 | 5.242e-14 | 2.489e-12 |
99 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 22 | 470 | 5.629e-14 | 2.646e-12 |
100 | RESPONSE TO RETINOIC ACID | 13 | 107 | 6.784e-14 | 3.157e-12 |
101 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 30 | 983 | 6.9e-14 | 3.179e-12 |
102 | SOMITOGENESIS | 11 | 62 | 8.13e-14 | 3.709e-12 |
103 | REGULATION OF CYTOPLASMIC TRANSPORT | 22 | 481 | 8.992e-14 | 4.062e-12 |
104 | POSITIVE REGULATION OF CELL CYCLE | 19 | 332 | 9.943e-14 | 4.448e-12 |
105 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 27 | 799 | 1.422e-13 | 6.301e-12 |
106 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 24 | 609 | 1.499e-13 | 6.578e-12 |
107 | NEGATIVE REGULATION OF GENE EXPRESSION | 36 | 1493 | 1.528e-13 | 6.645e-12 |
108 | SEGMENTATION | 12 | 89 | 1.804e-13 | 7.773e-12 |
109 | AXIS SPECIFICATION | 12 | 90 | 2.072e-13 | 8.843e-12 |
110 | DORSAL VENTRAL PATTERN FORMATION | 12 | 91 | 2.374e-13 | 1.004e-11 |
111 | REGULATION OF PROTEIN IMPORT | 15 | 183 | 2.672e-13 | 1.12e-11 |
112 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 41 | 1977 | 2.698e-13 | 1.121e-11 |
113 | CELLULAR RESPONSE TO LIPID | 21 | 457 | 3.207e-13 | 1.32e-11 |
114 | EMBRYONIC ORGAN DEVELOPMENT | 20 | 406 | 3.459e-13 | 1.412e-11 |
115 | NEURAL TUBE FORMATION | 12 | 94 | 3.541e-13 | 1.433e-11 |
116 | GASTRULATION | 14 | 155 | 4.569e-13 | 1.828e-11 |
117 | MESENCHYME DEVELOPMENT | 15 | 190 | 4.636e-13 | 1.828e-11 |
118 | STEM CELL DIFFERENTIATION | 15 | 190 | 4.636e-13 | 1.828e-11 |
119 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 34 | 1381 | 4.916e-13 | 1.922e-11 |
120 | PHOSPHORYLATION | 32 | 1228 | 6.282e-13 | 2.436e-11 |
121 | RESPONSE TO GROWTH FACTOR | 21 | 475 | 6.743e-13 | 2.593e-11 |
122 | CELL CYCLE | 33 | 1316 | 7.194e-13 | 2.744e-11 |
123 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 30 | 1079 | 7.621e-13 | 2.883e-11 |
124 | TUBE FORMATION | 13 | 129 | 7.909e-13 | 2.968e-11 |
125 | CELL CYCLE PROCESS | 30 | 1081 | 7.99e-13 | 2.974e-11 |
126 | REGULATION OF MAPK CASCADE | 24 | 660 | 8.426e-13 | 3.112e-11 |
127 | REGULATION OF HYDROLASE ACTIVITY | 33 | 1327 | 9.048e-13 | 3.315e-11 |
128 | EPITHELIAL TO MESENCHYMAL TRANSITION | 10 | 56 | 1.071e-12 | 3.892e-11 |
129 | NEGATIVE REGULATION OF CELL DEATH | 27 | 872 | 1.118e-12 | 4.031e-11 |
130 | REGULATION OF ORGANELLE ORGANIZATION | 31 | 1178 | 1.222e-12 | 4.374e-11 |
131 | REGULATION OF PROTEIN BINDING | 14 | 168 | 1.388e-12 | 4.932e-11 |
132 | FC RECEPTOR SIGNALING PATHWAY | 15 | 206 | 1.508e-12 | 5.314e-11 |
133 | RESPONSE TO LIPID | 27 | 888 | 1.709e-12 | 5.978e-11 |
134 | REGULATION OF TRANSPORT | 38 | 1804 | 1.734e-12 | 6.021e-11 |
135 | REGULATION OF INTRACELLULAR TRANSPORT | 23 | 621 | 1.854e-12 | 6.389e-11 |
136 | REGULATION OF PROTEIN CATABOLIC PROCESS | 19 | 393 | 1.984e-12 | 6.788e-11 |
137 | HEART MORPHOGENESIS | 15 | 212 | 2.286e-12 | 7.764e-11 |
138 | RHYTHMIC PROCESS | 17 | 298 | 2.317e-12 | 7.814e-11 |
139 | CELLULAR RESPONSE TO ACID CHEMICAL | 14 | 175 | 2.43e-12 | 8.136e-11 |
140 | MITOTIC CELL CYCLE | 25 | 766 | 2.83e-12 | 9.406e-11 |
141 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 16 | 258 | 3.04e-12 | 1.003e-10 |
142 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 13 | 144 | 3.281e-12 | 1.06e-10 |
143 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 25 | 771 | 3.261e-12 | 1.06e-10 |
144 | BETA CATENIN TCF COMPLEX ASSEMBLY | 9 | 43 | 3.271e-12 | 1.06e-10 |
145 | REGULATION OF STEM CELL DIFFERENTIATION | 12 | 113 | 3.334e-12 | 1.07e-10 |
146 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 15 | 218 | 3.422e-12 | 1.091e-10 |
147 | DOPAMINERGIC NEURON DIFFERENTIATION | 8 | 28 | 3.482e-12 | 1.102e-10 |
148 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 19 | 406 | 3.508e-12 | 1.103e-10 |
149 | VASCULATURE DEVELOPMENT | 20 | 469 | 4.883e-12 | 1.525e-10 |
150 | POSITIVE REGULATION OF CELL DEVELOPMENT | 20 | 472 | 5.482e-12 | 1.701e-10 |
151 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 15 | 228 | 6.527e-12 | 2.011e-10 |
152 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 12 | 121 | 7.59e-12 | 2.323e-10 |
153 | POSITIVE REGULATION OF KINASE ACTIVITY | 20 | 482 | 8.015e-12 | 2.438e-10 |
154 | DIGESTIVE TRACT MORPHOGENESIS | 9 | 48 | 9.491e-12 | 2.849e-10 |
155 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 24 | 740 | 9.437e-12 | 2.849e-10 |
156 | EMBRYONIC ORGAN MORPHOGENESIS | 16 | 279 | 9.947e-12 | 2.967e-10 |
157 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 16 | 282 | 1.169e-11 | 3.464e-10 |
158 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 22 | 616 | 1.219e-11 | 3.589e-10 |
159 | SENSORY ORGAN MORPHOGENESIS | 15 | 239 | 1.282e-11 | 3.75e-10 |
160 | DEVELOPMENTAL GROWTH | 17 | 333 | 1.356e-11 | 3.944e-10 |
161 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 24 | 767 | 1.99e-11 | 5.753e-10 |
162 | REGULATION OF GROWTH | 22 | 633 | 2.067e-11 | 5.937e-10 |
163 | GLAND DEVELOPMENT | 18 | 395 | 2.125e-11 | 6.067e-10 |
164 | REGULATION OF IMMUNE SYSTEM PROCESS | 32 | 1403 | 2.142e-11 | 6.079e-10 |
165 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 13 | 167 | 2.175e-11 | 6.134e-10 |
166 | CELL DEATH | 27 | 1001 | 2.691e-11 | 7.542e-10 |
167 | HEAD DEVELOPMENT | 23 | 709 | 2.713e-11 | 7.558e-10 |
168 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 12 | 135 | 2.798e-11 | 7.748e-10 |
169 | REGULATION OF PROTEOLYSIS | 23 | 711 | 2.87e-11 | 7.901e-10 |
170 | REGULATION OF IMMUNE RESPONSE | 25 | 858 | 3.271e-11 | 8.954e-10 |
171 | REPRODUCTIVE SYSTEM DEVELOPMENT | 18 | 408 | 3.62e-11 | 9.849e-10 |
172 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 17 | 360 | 4.618e-11 | 1.249e-09 |
173 | REGULATION OF CATABOLIC PROCESS | 23 | 731 | 4.989e-11 | 1.334e-09 |
174 | REGULATION OF JUN KINASE ACTIVITY | 10 | 81 | 4.988e-11 | 1.334e-09 |
175 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 25 | 876 | 5.089e-11 | 1.353e-09 |
176 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 11 | 112 | 6.547e-11 | 1.731e-09 |
177 | POSITIVE REGULATION OF CELL PROLIFERATION | 24 | 814 | 6.788e-11 | 1.784e-09 |
178 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 17 | 370 | 7.081e-11 | 1.851e-09 |
179 | PEPTIDYL SERINE MODIFICATION | 12 | 148 | 8.272e-11 | 2.146e-09 |
180 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 23 | 750 | 8.3e-11 | 2.146e-09 |
181 | EYE DEVELOPMENT | 16 | 326 | 1.017e-10 | 2.614e-09 |
182 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 11 | 117 | 1.056e-10 | 2.7e-09 |
183 | REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 14 | 1.129e-10 | 2.854e-09 |
184 | CONVERGENT EXTENSION | 6 | 14 | 1.129e-10 | 2.854e-09 |
185 | IMMUNE SYSTEM PROCESS | 37 | 1984 | 1.322e-10 | 3.31e-09 |
186 | NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT | 7 | 26 | 1.323e-10 | 3.31e-09 |
187 | MIDBRAIN DEVELOPMENT | 10 | 90 | 1.453e-10 | 3.614e-09 |
188 | REGULATION OF CELL GROWTH | 17 | 391 | 1.667e-10 | 4.126e-09 |
189 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 20 | 573 | 1.752e-10 | 4.314e-09 |
190 | REGULATION OF CATENIN IMPORT INTO NUCLEUS | 7 | 27 | 1.777e-10 | 4.33e-09 |
191 | AXIS ELONGATION | 7 | 27 | 1.777e-10 | 4.33e-09 |
192 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 289 | 1.873e-10 | 4.54e-09 |
193 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 19 | 514 | 2.013e-10 | 4.854e-09 |
194 | SKELETAL SYSTEM DEVELOPMENT | 18 | 455 | 2.133e-10 | 5.116e-09 |
195 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 67 | 2.202e-10 | 5.254e-09 |
196 | IMMUNE SYSTEM DEVELOPMENT | 20 | 582 | 2.303e-10 | 5.468e-09 |
197 | RESPONSE TO ENDOGENOUS STIMULUS | 31 | 1450 | 2.408e-10 | 5.687e-09 |
198 | SINGLE ORGANISM CELL ADHESION | 18 | 459 | 2.456e-10 | 5.772e-09 |
199 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 14 | 247 | 2.485e-10 | 5.811e-09 |
200 | PARAXIAL MESODERM DEVELOPMENT | 6 | 16 | 2.98e-10 | 6.934e-09 |
201 | REGULATION OF MITOTIC CELL CYCLE | 18 | 468 | 3.356e-10 | 7.77e-09 |
202 | GROWTH | 17 | 410 | 3.46e-10 | 7.97e-09 |
203 | WOUND HEALING | 18 | 470 | 3.594e-10 | 8.215e-09 |
204 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 11 | 131 | 3.601e-10 | 8.215e-09 |
205 | NEGATIVE REGULATION OF CELL GROWTH | 12 | 170 | 4.157e-10 | 9.435e-09 |
206 | MESENCHYMAL CELL DIFFERENTIATION | 11 | 134 | 4.597e-10 | 1.038e-08 |
207 | CELLULAR COMPONENT MORPHOGENESIS | 24 | 900 | 5.203e-10 | 1.169e-08 |
208 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 21 | 684 | 6.022e-10 | 1.347e-08 |
209 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 6 | 18 | 6.842e-10 | 1.523e-08 |
210 | REGULATION OF OSSIFICATION | 12 | 178 | 7.065e-10 | 1.565e-08 |
211 | RESPONSE TO ACID CHEMICAL | 15 | 319 | 7.364e-10 | 1.616e-08 |
212 | REGULATION OF MAP KINASE ACTIVITY | 15 | 319 | 7.364e-10 | 1.616e-08 |
213 | REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 12 | 181 | 8.561e-10 | 1.87e-08 |
214 | MAMMARY GLAND EPITHELIUM DEVELOPMENT | 8 | 53 | 8.776e-10 | 1.908e-08 |
215 | REGULATION OF CELL ADHESION | 20 | 629 | 8.895e-10 | 1.925e-08 |
216 | RESPONSE TO WOUNDING | 19 | 563 | 9.223e-10 | 1.987e-08 |
217 | NEGATIVE REGULATION OF CELL PROLIFERATION | 20 | 643 | 1.3e-09 | 2.787e-08 |
218 | DIGESTIVE SYSTEM DEVELOPMENT | 11 | 148 | 1.333e-09 | 2.845e-08 |
219 | LOCOMOTION | 26 | 1114 | 1.502e-09 | 3.192e-08 |
220 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 23 | 872 | 1.56e-09 | 3.3e-08 |
221 | NEGATIVE REGULATION OF GROWTH | 13 | 236 | 1.598e-09 | 3.364e-08 |
222 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 14 | 285 | 1.607e-09 | 3.367e-08 |
223 | EMBRYONIC PATTERN SPECIFICATION | 8 | 58 | 1.852e-09 | 3.863e-08 |
224 | CONNECTIVE TISSUE DEVELOPMENT | 12 | 194 | 1.893e-09 | 3.931e-08 |
225 | PALATE DEVELOPMENT | 9 | 85 | 1.939e-09 | 4.01e-08 |
226 | MAMMARY GLAND DEVELOPMENT | 10 | 117 | 1.98e-09 | 4.077e-08 |
227 | MESODERM DEVELOPMENT | 10 | 118 | 2.153e-09 | 4.413e-08 |
228 | MESENCHYME MORPHOGENESIS | 7 | 38 | 2.393e-09 | 4.884e-08 |
229 | STEM CELL PROLIFERATION | 8 | 60 | 2.447e-09 | 4.972e-08 |
230 | POSITIVE REGULATION OF MAPK CASCADE | 17 | 470 | 2.746e-09 | 5.555e-08 |
231 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 19 | 602 | 2.78e-09 | 5.599e-08 |
232 | UROGENITAL SYSTEM DEVELOPMENT | 14 | 299 | 2.979e-09 | 5.975e-08 |
233 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 8 | 63 | 3.65e-09 | 7.288e-08 |
234 | CELL CYCLE PHASE TRANSITION | 13 | 255 | 4.081e-09 | 8.081e-08 |
235 | LEUKOCYTE CELL CELL ADHESION | 13 | 255 | 4.081e-09 | 8.081e-08 |
236 | CELL CELL SIGNALING | 21 | 767 | 4.628e-09 | 9.124e-08 |
237 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 24 | 1008 | 4.889e-09 | 9.599e-08 |
238 | MESODERM MORPHOGENESIS | 8 | 66 | 5.333e-09 | 1.043e-07 |
239 | APPENDAGE DEVELOPMENT | 11 | 169 | 5.423e-09 | 1.051e-07 |
240 | LIMB DEVELOPMENT | 11 | 169 | 5.423e-09 | 1.051e-07 |
241 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 13 | 263 | 5.918e-09 | 1.143e-07 |
242 | MUSCLE STRUCTURE DEVELOPMENT | 16 | 432 | 5.994e-09 | 1.143e-07 |
243 | NEGATIVE REGULATION OF BINDING | 10 | 131 | 5.973e-09 | 1.143e-07 |
244 | POSITIVE REGULATION OF TRANSPORT | 23 | 936 | 5.98e-09 | 1.143e-07 |
245 | CELLULAR RESPONSE TO STRESS | 30 | 1565 | 6.552e-09 | 1.244e-07 |
246 | RESPONSE TO ABIOTIC STIMULUS | 24 | 1024 | 6.641e-09 | 1.256e-07 |
247 | REGULATION OF CELL JUNCTION ASSEMBLY | 8 | 68 | 6.796e-09 | 1.28e-07 |
248 | REGULATION OF CELL SUBSTRATE ADHESION | 11 | 173 | 6.931e-09 | 1.3e-07 |
249 | REPRODUCTION | 27 | 1297 | 7.996e-09 | 1.494e-07 |
250 | REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 13 | 274 | 9.663e-09 | 1.799e-07 |
251 | PEPTIDYL THREONINE MODIFICATION | 7 | 46 | 9.758e-09 | 1.809e-07 |
252 | POSITIVE REGULATION OF PROTEIN IMPORT | 9 | 104 | 1.178e-08 | 2.166e-07 |
253 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 9 | 104 | 1.178e-08 | 2.166e-07 |
254 | REGULATION OF FAT CELL DIFFERENTIATION | 9 | 106 | 1.394e-08 | 2.543e-07 |
255 | FAT CELL DIFFERENTIATION | 9 | 106 | 1.394e-08 | 2.543e-07 |
256 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 29 | 1527 | 1.538e-08 | 2.796e-07 |
257 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 22 | 905 | 1.635e-08 | 2.961e-07 |
258 | LYMPHOCYTE ACTIVATION | 14 | 342 | 1.643e-08 | 2.964e-07 |
259 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 50 | 1.786e-08 | 3.208e-07 |
260 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 15 | 404 | 1.798e-08 | 3.218e-07 |
261 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 8 | 77 | 1.85e-08 | 3.299e-07 |
262 | POSITIVE REGULATION OF GROWTH | 12 | 238 | 1.887e-08 | 3.351e-07 |
263 | FORMATION OF PRIMARY GERM LAYER | 9 | 110 | 1.932e-08 | 3.418e-07 |
264 | NEGATIVE REGULATION OF PROTEIN BINDING | 8 | 79 | 2.272e-08 | 4.004e-07 |
265 | LEUKOCYTE ACTIVATION | 15 | 414 | 2.485e-08 | 4.364e-07 |
266 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 10 | 154 | 2.834e-08 | 4.957e-07 |
267 | KIDNEY MORPHOGENESIS | 8 | 82 | 3.058e-08 | 5.329e-07 |
268 | POSITIVE REGULATION OF PROTEOLYSIS | 14 | 363 | 3.466e-08 | 6.017e-07 |
269 | BLOOD VESSEL MORPHOGENESIS | 14 | 364 | 3.586e-08 | 6.203e-07 |
270 | BIOLOGICAL ADHESION | 23 | 1032 | 3.659e-08 | 6.305e-07 |
271 | EMBRYONIC AXIS SPECIFICATION | 6 | 33 | 3.796e-08 | 6.517e-07 |
272 | OUTFLOW TRACT MORPHOGENESIS | 7 | 56 | 4.026e-08 | 6.862e-07 |
273 | EPITHELIAL CELL DIFFERENTIATION | 16 | 495 | 4.024e-08 | 6.862e-07 |
274 | SECOND MESSENGER MEDIATED SIGNALING | 10 | 160 | 4.077e-08 | 6.924e-07 |
275 | RESPONSE TO DRUG | 15 | 431 | 4.222e-08 | 7.144e-07 |
276 | NEGATIVE REGULATION OF CELL CYCLE | 15 | 433 | 4.486e-08 | 7.563e-07 |
277 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 34 | 4.587e-08 | 7.65e-07 |
278 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 6 | 34 | 4.587e-08 | 7.65e-07 |
279 | BRAIN MORPHOGENESIS | 6 | 34 | 4.587e-08 | 7.65e-07 |
280 | REGULATION OF STEM CELL PROLIFERATION | 8 | 88 | 5.353e-08 | 8.896e-07 |
281 | POST ANAL TAIL MORPHOGENESIS | 5 | 18 | 5.519e-08 | 9.138e-07 |
282 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 12 | 263 | 5.677e-08 | 9.367e-07 |
283 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 10 | 166 | 5.78e-08 | 9.503e-07 |
284 | KIDNEY EPITHELIUM DEVELOPMENT | 9 | 125 | 5.905e-08 | 9.674e-07 |
285 | REGULATION OF CELL CYCLE PHASE TRANSITION | 13 | 321 | 6.255e-08 | 1.021e-06 |
286 | CALCIUM MEDIATED SIGNALING | 8 | 90 | 6.392e-08 | 1.036e-06 |
287 | MESONEPHROS DEVELOPMENT | 8 | 90 | 6.392e-08 | 1.036e-06 |
288 | REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 7 | 60 | 6.574e-08 | 1.062e-06 |
289 | EMBRYONIC DIGIT MORPHOGENESIS | 7 | 61 | 7.39e-08 | 1.19e-06 |
290 | REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 5 | 19 | 7.454e-08 | 1.196e-06 |
291 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 9 | 129 | 7.758e-08 | 1.241e-06 |
292 | REGULATION OF MUSCLE ADAPTATION | 7 | 63 | 9.28e-08 | 1.479e-06 |
293 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 23 | 1087 | 9.391e-08 | 1.491e-06 |
294 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 21 | 917 | 9.981e-08 | 1.58e-06 |
295 | CELL CELL ADHESION | 17 | 608 | 1.187e-07 | 1.872e-06 |
296 | EYE MORPHOGENESIS | 9 | 136 | 1.224e-07 | 1.924e-06 |
297 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 11 | 229 | 1.243e-07 | 1.948e-06 |
298 | REGULATION OF MEIOTIC CELL CYCLE | 6 | 40 | 1.272e-07 | 1.979e-06 |
299 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 6 | 40 | 1.272e-07 | 1.979e-06 |
300 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 7 | 66 | 1.287e-07 | 1.996e-06 |
301 | POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 21 | 1.292e-07 | 1.997e-06 |
302 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 16 | 541 | 1.358e-07 | 2.085e-06 |
303 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 16 | 541 | 1.358e-07 | 2.085e-06 |
304 | MACROMOLECULAR COMPLEX DISASSEMBLY | 10 | 182 | 1.373e-07 | 2.102e-06 |
305 | REGULATION OF DEVELOPMENTAL GROWTH | 12 | 289 | 1.583e-07 | 2.407e-06 |
306 | CAMERA TYPE EYE MORPHOGENESIS | 8 | 101 | 1.578e-07 | 2.407e-06 |
307 | SOMATIC STEM CELL DIVISION | 5 | 22 | 1.664e-07 | 2.522e-06 |
308 | REGULATION OF CIRCADIAN RHYTHM | 8 | 103 | 1.839e-07 | 2.769e-06 |
309 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 8 | 103 | 1.839e-07 | 2.769e-06 |
310 | REGULATION OF NEURON DIFFERENTIATION | 16 | 554 | 1.872e-07 | 2.8e-06 |
311 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 20 | 867 | 1.869e-07 | 2.8e-06 |
312 | NEURAL PRECURSOR CELL PROLIFERATION | 7 | 70 | 1.943e-07 | 2.897e-06 |
313 | FOREBRAIN DEVELOPMENT | 13 | 357 | 2.136e-07 | 3.176e-06 |
314 | PROTEIN AUTOPHOSPHORYLATION | 10 | 192 | 2.261e-07 | 3.35e-06 |
315 | RESPONSE TO CYTOKINE | 18 | 714 | 2.268e-07 | 3.35e-06 |
316 | INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 8 | 106 | 2.298e-07 | 3.384e-06 |
317 | CARTILAGE DEVELOPMENT | 9 | 147 | 2.383e-07 | 3.497e-06 |
318 | REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 9 | 148 | 2.524e-07 | 3.693e-06 |
319 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 13 | 363 | 2.585e-07 | 3.77e-06 |
320 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 12 | 303 | 2.633e-07 | 3.816e-06 |
321 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 12 | 303 | 2.633e-07 | 3.816e-06 |
322 | POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 5 | 24 | 2.661e-07 | 3.833e-06 |
323 | REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY | 5 | 24 | 2.661e-07 | 3.833e-06 |
324 | RESPIRATORY SYSTEM DEVELOPMENT | 10 | 197 | 2.869e-07 | 4.121e-06 |
325 | REGULATION OF CYTOSKELETON ORGANIZATION | 15 | 502 | 3.032e-07 | 4.34e-06 |
326 | REGULATION OF CELLULAR RESPONSE TO HEAT | 7 | 76 | 3.44e-07 | 4.911e-06 |
327 | SKELETAL SYSTEM MORPHOGENESIS | 10 | 201 | 3.455e-07 | 4.917e-06 |
328 | IN UTERO EMBRYONIC DEVELOPMENT | 12 | 311 | 3.479e-07 | 4.935e-06 |
329 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 12 | 312 | 3.6e-07 | 5.091e-06 |
330 | POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 4 | 11 | 3.807e-07 | 5.368e-06 |
331 | POSITIVE REGULATION OF CELL ADHESION | 13 | 376 | 3.858e-07 | 5.423e-06 |
332 | POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 6 | 48 | 3.911e-07 | 5.481e-06 |
333 | CELLULAR COMPONENT DISASSEMBLY | 15 | 515 | 4.194e-07 | 5.86e-06 |
334 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 10 | 207 | 4.531e-07 | 6.312e-06 |
335 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 11 | 262 | 4.785e-07 | 6.646e-06 |
336 | NEGATIVE REGULATION OF LOCOMOTION | 11 | 263 | 4.969e-07 | 6.879e-06 |
337 | DEVELOPMENTAL INDUCTION | 5 | 27 | 4.982e-07 | 6.879e-06 |
338 | REGULATION OF ADHERENS JUNCTION ORGANIZATION | 6 | 50 | 5.015e-07 | 6.904e-06 |
339 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 11 | 264 | 5.16e-07 | 7.082e-06 |
340 | SEX DIFFERENTIATION | 11 | 266 | 5.56e-07 | 7.608e-06 |
341 | PROTEASOMAL PROTEIN CATABOLIC PROCESS | 11 | 271 | 6.682e-07 | 9.118e-06 |
342 | POSITIVE REGULATION OF CATABOLIC PROCESS | 13 | 395 | 6.731e-07 | 9.157e-06 |
343 | POSITIVE REGULATION OF OSSIFICATION | 7 | 84 | 6.854e-07 | 9.298e-06 |
344 | REGULATION OF CELL DIVISION | 11 | 272 | 6.929e-07 | 9.372e-06 |
345 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 14 | 465 | 7.083e-07 | 9.552e-06 |
346 | STEM CELL DIVISION | 5 | 29 | 7.259e-07 | 9.762e-06 |
347 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 16 | 616 | 7.692e-07 | 1.031e-05 |
348 | HEMATOPOIETIC STEM CELL PROLIFERATION | 4 | 13 | 8.173e-07 | 1.087e-05 |
349 | REGULATION OF CELL FATE SPECIFICATION | 4 | 13 | 8.173e-07 | 1.087e-05 |
350 | REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 4 | 13 | 8.173e-07 | 1.087e-05 |
351 | REGULATION OF PROTEIN STABILITY | 10 | 221 | 8.248e-07 | 1.093e-05 |
352 | NEURON PROJECTION DEVELOPMENT | 15 | 545 | 8.549e-07 | 1.127e-05 |
353 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 9 | 171 | 8.55e-07 | 1.127e-05 |
354 | OSTEOBLAST DIFFERENTIATION | 8 | 126 | 8.671e-07 | 1.136e-05 |
355 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 8 | 126 | 8.671e-07 | 1.136e-05 |
356 | REGULATION OF PHOSPHATASE ACTIVITY | 8 | 128 | 9.773e-07 | 1.277e-05 |
357 | EPITHELIAL CELL PROLIFERATION | 7 | 89 | 1.017e-06 | 1.326e-05 |
358 | REGULATION OF CELL MATRIX ADHESION | 7 | 90 | 1.098e-06 | 1.427e-05 |
359 | CELL MIGRATION INVOLVED IN GASTRULATION | 4 | 14 | 1.139e-06 | 1.476e-05 |
360 | REGULATION OF CELL PROJECTION ORGANIZATION | 15 | 558 | 1.147e-06 | 1.482e-05 |
361 | INNER EAR MORPHOGENESIS | 7 | 92 | 1.275e-06 | 1.643e-05 |
362 | POSITIVE REGULATION OF LOCOMOTION | 13 | 420 | 1.336e-06 | 1.717e-05 |
363 | LEUKOCYTE DIFFERENTIATION | 11 | 292 | 1.389e-06 | 1.78e-05 |
364 | NEGATIVE REGULATION OF PHOSPHORYLATION | 13 | 422 | 1.408e-06 | 1.8e-05 |
365 | POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 5 | 33 | 1.424e-06 | 1.815e-05 |
366 | ANGIOGENESIS | 11 | 293 | 1.436e-06 | 1.825e-05 |
367 | CHONDROCYTE DIFFERENTIATION | 6 | 60 | 1.505e-06 | 1.909e-05 |
368 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 23 | 1275 | 1.539e-06 | 1.946e-05 |
369 | REGULATION OF MESODERM DEVELOPMENT | 4 | 15 | 1.546e-06 | 1.949e-05 |
370 | MUSCLE CELL DIFFERENTIATION | 10 | 237 | 1.554e-06 | 1.955e-05 |
371 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 7 | 95 | 1.584e-06 | 1.982e-05 |
372 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 7 | 95 | 1.584e-06 | 1.982e-05 |
373 | PROTEIN DESTABILIZATION | 5 | 34 | 1.661e-06 | 2.072e-05 |
374 | RESPONSE TO ALCOHOL | 12 | 362 | 1.721e-06 | 2.142e-05 |
375 | CELL CYCLE G2 M PHASE TRANSITION | 8 | 138 | 1.726e-06 | 2.142e-05 |
376 | REGULATION OF SMOOTHENED SIGNALING PATHWAY | 6 | 62 | 1.831e-06 | 2.259e-05 |
377 | EMBRYONIC HEART TUBE MORPHOGENESIS | 6 | 62 | 1.831e-06 | 2.259e-05 |
378 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 18 | 829 | 1.953e-06 | 2.404e-05 |
379 | REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 63 | 2.014e-06 | 2.472e-05 |
380 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 7 | 99 | 2.093e-06 | 2.563e-05 |
381 | PLATELET ACTIVATION | 8 | 142 | 2.14e-06 | 2.613e-05 |
382 | CELL MOTILITY | 18 | 835 | 2.162e-06 | 2.626e-05 |
383 | LOCALIZATION OF CELL | 18 | 835 | 2.162e-06 | 2.626e-05 |
384 | RESPONSE TO EXTERNAL STIMULUS | 28 | 1821 | 2.19e-06 | 2.653e-05 |
385 | CARDIAC CHAMBER DEVELOPMENT | 8 | 144 | 2.377e-06 | 2.865e-05 |
386 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 8 | 144 | 2.377e-06 | 2.865e-05 |
387 | PEPTIDYL AMINO ACID MODIFICATION | 18 | 841 | 2.391e-06 | 2.875e-05 |
388 | NEGATIVE REGULATION OF KINASE ACTIVITY | 10 | 250 | 2.511e-06 | 3.011e-05 |
389 | OSSIFICATION | 10 | 251 | 2.602e-06 | 3.112e-05 |
390 | REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 4 | 17 | 2.671e-06 | 3.154e-05 |
391 | SOMATIC STEM CELL POPULATION MAINTENANCE | 6 | 66 | 2.654e-06 | 3.154e-05 |
392 | REGULATION OF CHROMATIN BINDING | 4 | 17 | 2.671e-06 | 3.154e-05 |
393 | ESTABLISHMENT OF TISSUE POLARITY | 4 | 17 | 2.671e-06 | 3.154e-05 |
394 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 17 | 2.671e-06 | 3.154e-05 |
395 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 7 | 103 | 2.732e-06 | 3.21e-05 |
396 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 7 | 103 | 2.732e-06 | 3.21e-05 |
397 | CARDIAC CHAMBER MORPHOGENESIS | 7 | 104 | 2.915e-06 | 3.41e-05 |
398 | POSITIVE REGULATION OF CELL GROWTH | 8 | 148 | 2.917e-06 | 3.41e-05 |
399 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 9 | 199 | 3.004e-06 | 3.503e-05 |
400 | PROTEIN COMPLEX BIOGENESIS | 21 | 1132 | 3.055e-06 | 3.545e-05 |
401 | PROTEIN COMPLEX ASSEMBLY | 21 | 1132 | 3.055e-06 | 3.545e-05 |
402 | NEURON DEVELOPMENT | 16 | 687 | 3.165e-06 | 3.664e-05 |
403 | RESPONSE TO NITROGEN COMPOUND | 18 | 859 | 3.216e-06 | 3.713e-05 |
404 | NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 5 | 39 | 3.356e-06 | 3.866e-05 |
405 | REGULATION OF CELL MATURATION | 4 | 18 | 3.418e-06 | 3.917e-05 |
406 | PERICARDIUM DEVELOPMENT | 4 | 18 | 3.418e-06 | 3.917e-05 |
407 | CELL DIVISION | 13 | 460 | 3.632e-06 | 4.152e-05 |
408 | AMEBOIDAL TYPE CELL MIGRATION | 8 | 154 | 3.922e-06 | 4.472e-05 |
409 | NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 7 | 109 | 3.989e-06 | 4.538e-05 |
410 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 8 | 156 | 4.316e-06 | 4.898e-05 |
411 | LYMPHOCYTE DIFFERENTIATION | 9 | 209 | 4.484e-06 | 5.076e-05 |
412 | REGULATION OF DEPHOSPHORYLATION | 8 | 158 | 4.743e-06 | 5.357e-05 |
413 | EAR MORPHOGENESIS | 7 | 112 | 4.78e-06 | 5.385e-05 |
414 | EMBRYONIC HEART TUBE DEVELOPMENT | 6 | 73 | 4.807e-06 | 5.402e-05 |
415 | SKIN DEVELOPMENT | 9 | 211 | 4.845e-06 | 5.432e-05 |
416 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 213 | 5.231e-06 | 5.851e-05 |
417 | BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 4 | 20 | 5.363e-06 | 5.984e-05 |
418 | NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 5 | 43 | 5.506e-06 | 6.087e-05 |
419 | REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 5 | 43 | 5.506e-06 | 6.087e-05 |
420 | RESPONSE TO HORMONE | 18 | 893 | 5.507e-06 | 6.087e-05 |
421 | MORPHOGENESIS OF AN EPITHELIAL SHEET | 5 | 43 | 5.506e-06 | 6.087e-05 |
422 | NEPHRON DEVELOPMENT | 7 | 115 | 5.696e-06 | 6.281e-05 |
423 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 12 | 408 | 5.875e-06 | 6.463e-05 |
424 | LABYRINTHINE LAYER DEVELOPMENT | 5 | 44 | 6.182e-06 | 6.785e-05 |
425 | CELL PROJECTION ORGANIZATION | 18 | 902 | 6.322e-06 | 6.921e-05 |
426 | SPECIFICATION OF SYMMETRY | 7 | 117 | 6.385e-06 | 6.974e-05 |
427 | REGULATION OF CYTOKINE PRODUCTION | 14 | 563 | 6.556e-06 | 7.122e-05 |
428 | REGULATION OF BMP SIGNALING PATHWAY | 6 | 77 | 6.566e-06 | 7.122e-05 |
429 | POSITIVE REGULATION OF IMMUNE RESPONSE | 14 | 563 | 6.556e-06 | 7.122e-05 |
430 | COCHLEA MORPHOGENESIS | 4 | 21 | 6.594e-06 | 7.135e-05 |
431 | RENAL TUBULE DEVELOPMENT | 6 | 78 | 7.079e-06 | 7.643e-05 |
432 | REGULATION OF AXONOGENESIS | 8 | 168 | 7.457e-06 | 8.032e-05 |
433 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 7 | 121 | 7.971e-06 | 8.566e-05 |
434 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 7 | 122 | 8.415e-06 | 9.022e-05 |
435 | T CELL DIFFERENTIATION | 7 | 123 | 8.88e-06 | 9.498e-05 |
436 | ACTIVATION OF IMMUNE RESPONSE | 12 | 427 | 9.297e-06 | 9.922e-05 |
437 | ANTERIOR POSTERIOR AXIS SPECIFICATION | 5 | 48 | 9.564e-06 | 0.0001018 |
438 | REGULATION OF OSTEOBLAST PROLIFERATION | 4 | 23 | 9.667e-06 | 0.0001025 |
439 | SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 4 | 23 | 9.667e-06 | 0.0001025 |
440 | POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 8 | 175 | 1.006e-05 | 0.0001063 |
441 | RESPONSE TO UV | 7 | 126 | 1.04e-05 | 0.0001097 |
442 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 9 | 232 | 1.042e-05 | 0.0001097 |
443 | CARDIAC SEPTUM MORPHOGENESIS | 5 | 49 | 1.06e-05 | 0.0001113 |
444 | REGULATION OF VASCULATURE DEVELOPMENT | 9 | 233 | 1.078e-05 | 0.000113 |
445 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 6 | 84 | 1.088e-05 | 0.0001138 |
446 | CARDIAC SEPTUM DEVELOPMENT | 6 | 85 | 1.165e-05 | 0.0001216 |
447 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 12 | 437 | 1.172e-05 | 0.000122 |
448 | REGULATION OF REPRODUCTIVE PROCESS | 7 | 129 | 1.213e-05 | 0.000126 |
449 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 11 | 368 | 1.261e-05 | 0.0001307 |
450 | RESPONSE TO EXTRACELLULAR STIMULUS | 12 | 441 | 1.283e-05 | 0.0001327 |
451 | POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 5 | 51 | 1.294e-05 | 0.0001332 |
452 | POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 5 | 51 | 1.294e-05 | 0.0001332 |
453 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 11 | 370 | 1.326e-05 | 0.0001362 |
454 | LENS FIBER CELL DIFFERENTIATION | 4 | 25 | 1.368e-05 | 0.0001402 |
455 | MAINTENANCE OF CELL NUMBER | 7 | 132 | 1.41e-05 | 0.0001442 |
456 | EPITHELIAL CELL DEVELOPMENT | 8 | 186 | 1.566e-05 | 0.0001595 |
457 | MESONEPHRIC TUBULE MORPHOGENESIS | 5 | 53 | 1.565e-05 | 0.0001595 |
458 | REGULATION OF CELL FATE COMMITMENT | 4 | 26 | 1.61e-05 | 0.0001635 |
459 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 9 | 246 | 1.662e-05 | 0.0001685 |
460 | RESPONSE TO OXYGEN LEVELS | 10 | 311 | 1.706e-05 | 0.0001722 |
461 | HEMOSTASIS | 10 | 311 | 1.706e-05 | 0.0001722 |
462 | CELLULAR RESPONSE TO RADIATION | 7 | 137 | 1.796e-05 | 0.0001808 |
463 | PROTEIN DEPHOSPHORYLATION | 8 | 190 | 1.827e-05 | 0.0001832 |
464 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 8 | 190 | 1.827e-05 | 0.0001832 |
465 | NEGATIVE REGULATION OF TRANSPORT | 12 | 458 | 1.867e-05 | 0.0001868 |
466 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 4 | 27 | 1.881e-05 | 0.0001875 |
467 | PLACENTA DEVELOPMENT | 7 | 138 | 1.882e-05 | 0.0001875 |
468 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 8 | 191 | 1.897e-05 | 0.0001886 |
469 | NEPHRON EPITHELIUM DEVELOPMENT | 6 | 93 | 1.954e-05 | 0.0001939 |
470 | MITOTIC CELL CYCLE CHECKPOINT | 7 | 139 | 1.972e-05 | 0.0001953 |
471 | TAXIS | 12 | 464 | 2.123e-05 | 0.0002097 |
472 | ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 7 | 141 | 2.164e-05 | 0.0002133 |
473 | VENTRICULAR SEPTUM MORPHOGENESIS | 4 | 28 | 2.184e-05 | 0.0002135 |
474 | GASTRULATION WITH MOUTH FORMING SECOND | 4 | 28 | 2.184e-05 | 0.0002135 |
475 | MORPHOGENESIS OF A POLARIZED EPITHELIUM | 4 | 28 | 2.184e-05 | 0.0002135 |
476 | MAMMARY GLAND DUCT MORPHOGENESIS | 4 | 28 | 2.184e-05 | 0.0002135 |
477 | REGULATION OF MUSCLE SYSTEM PROCESS | 8 | 195 | 2.202e-05 | 0.0002148 |
478 | REGULATION OF PEPTIDE TRANSPORT | 9 | 256 | 2.278e-05 | 0.0002217 |
479 | MACROMOLECULAR COMPLEX ASSEMBLY | 22 | 1398 | 2.339e-05 | 0.0002272 |
480 | POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 8 | 197 | 2.37e-05 | 0.0002297 |
481 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 15 | 724 | 2.614e-05 | 0.0002529 |
482 | REGULATION OF HORMONE LEVELS | 12 | 478 | 2.84e-05 | 0.0002742 |
483 | NEURON PROJECTION MORPHOGENESIS | 11 | 402 | 2.851e-05 | 0.0002747 |
484 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 5 | 60 | 2.882e-05 | 0.0002771 |
485 | RESPONSE TO INORGANIC SUBSTANCE | 12 | 479 | 2.899e-05 | 0.0002781 |
486 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 6 | 100 | 2.954e-05 | 0.0002825 |
487 | MALE SEX DIFFERENTIATION | 7 | 148 | 2.956e-05 | 0.0002825 |
488 | ACTIVATION OF INNATE IMMUNE RESPONSE | 8 | 204 | 3.043e-05 | 0.0002901 |
489 | RESPONSE TO METAL ION | 10 | 333 | 3.06e-05 | 0.0002911 |
490 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 5 | 61 | 3.124e-05 | 0.0002967 |
491 | NEURON PROJECTION GUIDANCE | 8 | 205 | 3.151e-05 | 0.0002986 |
492 | POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 3 | 11 | 3.273e-05 | 0.0003095 |
493 | REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 4 | 31 | 3.311e-05 | 0.0003119 |
494 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 6 | 102 | 3.305e-05 | 0.0003119 |
495 | NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 8 | 209 | 3.615e-05 | 0.0003398 |
496 | REGULATION OF CARTILAGE DEVELOPMENT | 5 | 63 | 3.657e-05 | 0.0003418 |
497 | PALLIUM DEVELOPMENT | 7 | 153 | 3.658e-05 | 0.0003418 |
498 | RESPONSE TO RADIATION | 11 | 413 | 3.646e-05 | 0.0003418 |
499 | REGULATION OF ORGAN FORMATION | 4 | 32 | 3.767e-05 | 0.0003505 |
500 | PATTERNING OF BLOOD VESSELS | 4 | 32 | 3.767e-05 | 0.0003505 |
501 | NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 5 | 64 | 3.948e-05 | 0.0003667 |
502 | COVALENT CHROMATIN MODIFICATION | 10 | 345 | 4.127e-05 | 0.0003825 |
503 | SYSTEM PROCESS | 25 | 1785 | 4.22e-05 | 0.0003904 |
504 | NEGATIVE REGULATION OF AXONOGENESIS | 5 | 65 | 4.257e-05 | 0.000393 |
505 | POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 3 | 12 | 4.345e-05 | 0.0003964 |
506 | REGULATION OF CHROMOSOME ORGANIZATION | 9 | 278 | 4.339e-05 | 0.0003964 |
507 | POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS | 3 | 12 | 4.345e-05 | 0.0003964 |
508 | MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 3 | 12 | 4.345e-05 | 0.0003964 |
509 | REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 3 | 12 | 4.345e-05 | 0.0003964 |
510 | LENS FIBER CELL DEVELOPMENT | 3 | 12 | 4.345e-05 | 0.0003964 |
511 | CELLULAR RESPONSE TO UV | 5 | 66 | 4.584e-05 | 0.0004149 |
512 | FOREBRAIN GENERATION OF NEURONS | 5 | 66 | 4.584e-05 | 0.0004149 |
513 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 6 | 108 | 4.563e-05 | 0.0004149 |
514 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 8 | 216 | 4.566e-05 | 0.0004149 |
515 | REGULATION OF GTPASE ACTIVITY | 14 | 673 | 4.74e-05 | 0.0004282 |
516 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 10 | 351 | 4.77e-05 | 0.0004302 |
517 | NEURAL TUBE PATTERNING | 4 | 34 | 4.813e-05 | 0.0004332 |
518 | PROTEIN LOCALIZATION | 25 | 1805 | 5.069e-05 | 0.0004553 |
519 | BONE REMODELING | 4 | 35 | 5.409e-05 | 0.000484 |
520 | REGULATION OF GASTRULATION | 4 | 35 | 5.409e-05 | 0.000484 |
521 | REGULATION OF NUCLEAR DIVISION | 7 | 163 | 5.473e-05 | 0.0004888 |
522 | REGULATION OF SKELETAL MUSCLE ADAPTATION | 3 | 13 | 5.624e-05 | 0.0005013 |
523 | POSITIVE REGULATION OF AXONOGENESIS | 5 | 69 | 5.683e-05 | 0.0005046 |
524 | SYNAPSE ASSEMBLY | 5 | 69 | 5.683e-05 | 0.0005046 |
525 | APOPTOTIC SIGNALING PATHWAY | 9 | 289 | 5.856e-05 | 0.000519 |
526 | POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 167 | 6.38e-05 | 0.0005644 |
527 | RESPONSE TO CALCIUM ION | 6 | 115 | 6.486e-05 | 0.0005727 |
528 | NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 5 | 71 | 6.522e-05 | 0.0005747 |
529 | RESPONSE TO CARBOHYDRATE | 7 | 168 | 6.625e-05 | 0.0005828 |
530 | TELENCEPHALON DEVELOPMENT | 8 | 228 | 6.68e-05 | 0.0005865 |
531 | REGULATION OF MUSCLE HYPERTROPHY | 4 | 37 | 6.761e-05 | 0.0005924 |
532 | POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 3 | 14 | 7.127e-05 | 0.000621 |
533 | REGULATION OF SECRETION | 14 | 699 | 7.115e-05 | 0.000621 |
534 | REGULATION OF MONOCYTE DIFFERENTIATION | 3 | 14 | 7.127e-05 | 0.000621 |
535 | NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 5 | 73 | 7.453e-05 | 0.000647 |
536 | POSITIVE REGULATION OF PROTEIN BINDING | 5 | 73 | 7.453e-05 | 0.000647 |
537 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 8 | 232 | 7.544e-05 | 0.0006537 |
538 | G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 19 | 1193 | 7.783e-05 | 0.0006731 |
539 | STRIATED MUSCLE CELL DIFFERENTIATION | 7 | 173 | 7.969e-05 | 0.0006879 |
540 | MODULATION OF SYNAPTIC TRANSMISSION | 9 | 301 | 7.999e-05 | 0.0006892 |
541 | COCHLEA DEVELOPMENT | 4 | 39 | 8.343e-05 | 0.0007175 |
542 | NEURAL CREST CELL DIFFERENTIATION | 5 | 75 | 8.483e-05 | 0.0007283 |
543 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 3 | 15 | 8.87e-05 | 0.0007601 |
544 | CHROMATIN MODIFICATION | 12 | 539 | 9e-05 | 0.0007698 |
545 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 9 | 306 | 9.068e-05 | 0.0007742 |
546 | MAMMARY GLAND MORPHOGENESIS | 4 | 40 | 9.227e-05 | 0.0007849 |
547 | NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 4 | 40 | 9.227e-05 | 0.0007849 |
548 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 6 | 123 | 9.425e-05 | 0.0008003 |
549 | CHROMOSOME ORGANIZATION | 17 | 1009 | 9.83e-05 | 0.0008332 |
550 | NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 4 | 41 | 0.0001018 | 0.0008611 |
551 | APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 3 | 16 | 0.0001087 | 0.0009162 |
552 | CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 3 | 16 | 0.0001087 | 0.0009162 |
553 | NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 4 | 42 | 0.000112 | 0.0009405 |
554 | EPITHELIAL CELL MORPHOGENESIS | 4 | 42 | 0.000112 | 0.0009405 |
555 | POSITIVE REGULATION OF BINDING | 6 | 127 | 0.0001125 | 0.0009429 |
556 | HEPATICOBILIARY SYSTEM DEVELOPMENT | 6 | 128 | 0.0001174 | 0.0009792 |
557 | REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 128 | 0.0001174 | 0.0009792 |
558 | MUSCLE CELL DEVELOPMENT | 6 | 128 | 0.0001174 | 0.0009792 |
559 | REGULATION OF FIBROBLAST PROLIFERATION | 5 | 81 | 0.0001224 | 0.001019 |
560 | JNK CASCADE | 5 | 82 | 0.0001297 | 0.001078 |
561 | COGNITION | 8 | 251 | 0.0001302 | 0.00108 |
562 | NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 3 | 17 | 0.0001314 | 0.001088 |
563 | PROTEIN STABILIZATION | 6 | 131 | 0.0001334 | 0.001102 |
564 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 7 | 188 | 0.0001339 | 0.001104 |
565 | BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 4 | 44 | 0.0001346 | 0.001108 |
566 | EMBRYONIC PLACENTA DEVELOPMENT | 5 | 83 | 0.0001374 | 0.00113 |
567 | THYMOCYTE AGGREGATION | 4 | 45 | 0.000147 | 0.001204 |
568 | T CELL DIFFERENTIATION IN THYMUS | 4 | 45 | 0.000147 | 0.001204 |
569 | POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 7 | 192 | 0.0001525 | 0.001247 |
570 | NEGATIVE REGULATION OF PROTEOLYSIS | 9 | 329 | 0.0001567 | 0.001277 |
571 | NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 6 | 135 | 0.0001573 | 0.001277 |
572 | UTERUS DEVELOPMENT | 3 | 18 | 0.000157 | 0.001277 |
573 | SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 3 | 18 | 0.000157 | 0.001277 |
574 | CHROMATIN ORGANIZATION | 13 | 663 | 0.0001614 | 0.001308 |
575 | CELL CYCLE CHECKPOINT | 7 | 194 | 0.0001626 | 0.001315 |
576 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 7 | 195 | 0.0001678 | 0.001353 |
577 | EAR DEVELOPMENT | 7 | 195 | 0.0001678 | 0.001353 |
578 | REGULATION OF HORMONE SECRETION | 8 | 262 | 0.0001746 | 0.001406 |
579 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 5 | 88 | 0.0001811 | 0.001455 |
580 | POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 19 | 0.0001856 | 0.001489 |
581 | REGULATION OF SYNAPTIC PLASTICITY | 6 | 140 | 0.0001917 | 0.001535 |
582 | REGULATION OF DNA METABOLIC PROCESS | 9 | 340 | 0.0002002 | 0.001601 |
583 | ENDOTHELIUM DEVELOPMENT | 5 | 90 | 0.0002012 | 0.001606 |
584 | CELLULAR RESPONSE TO LIGHT STIMULUS | 5 | 91 | 0.0002119 | 0.001689 |
585 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 7 | 203 | 0.0002148 | 0.001708 |
586 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 11 | 505 | 0.0002161 | 0.001716 |
587 | TONGUE DEVELOPMENT | 3 | 20 | 0.0002175 | 0.001718 |
588 | TRACHEA DEVELOPMENT | 3 | 20 | 0.0002175 | 0.001718 |
589 | POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 3 | 20 | 0.0002175 | 0.001718 |
590 | REGULATION OF BODY FLUID LEVELS | 11 | 506 | 0.0002198 | 0.001733 |
591 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 4 | 50 | 0.0002221 | 0.001746 |
592 | RHO PROTEIN SIGNAL TRANSDUCTION | 4 | 50 | 0.0002221 | 0.001746 |
593 | SYNAPTIC SIGNALING | 10 | 424 | 0.0002247 | 0.001763 |
594 | SYNAPSE ORGANIZATION | 6 | 145 | 0.0002319 | 0.001814 |
595 | NEGATIVE REGULATION OF MAPK CASCADE | 6 | 145 | 0.0002319 | 0.001814 |
596 | REGULATION OF DNA BINDING | 5 | 93 | 0.0002346 | 0.001832 |
597 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 6 | 146 | 0.0002407 | 0.001876 |
598 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 7 | 207 | 0.0002419 | 0.001883 |
599 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 6 | 147 | 0.0002497 | 0.00194 |
600 | APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 3 | 21 | 0.0002526 | 0.001959 |
601 | MUSCLE ORGAN DEVELOPMENT | 8 | 277 | 0.0002548 | 0.001972 |
602 | REGULATION OF PEPTIDE SECRETION | 7 | 209 | 0.0002565 | 0.001983 |
603 | NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 5 | 95 | 0.0002591 | 0.001999 |
604 | RESPONSE TO MECHANICAL STIMULUS | 7 | 210 | 0.0002641 | 0.002034 |
605 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 12 | 606 | 0.0002666 | 0.002051 |
606 | RESPONSE TO LIGHT STIMULUS | 8 | 280 | 0.0002739 | 0.002103 |
607 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 4 | 53 | 0.0002786 | 0.002132 |
608 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 4 | 53 | 0.0002786 | 0.002132 |
609 | GLAND MORPHOGENESIS | 5 | 97 | 0.0002855 | 0.002181 |
610 | REGULATION OF INNATE IMMUNE RESPONSE | 9 | 357 | 0.0002871 | 0.00219 |
611 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 7 | 213 | 0.0002878 | 0.002192 |
612 | CEREBRAL CORTEX NEURON DIFFERENTIATION | 3 | 22 | 0.0002912 | 0.002196 |
613 | MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 3 | 22 | 0.0002912 | 0.002196 |
614 | POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 3 | 22 | 0.0002912 | 0.002196 |
615 | POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY | 3 | 22 | 0.0002912 | 0.002196 |
616 | REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 3 | 22 | 0.0002912 | 0.002196 |
617 | EMBRYONIC PLACENTA MORPHOGENESIS | 3 | 22 | 0.0002912 | 0.002196 |
618 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 7 | 214 | 0.0002961 | 0.00223 |
619 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 4 | 54 | 0.0002995 | 0.00224 |
620 | POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 5 | 98 | 0.0002994 | 0.00224 |
621 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 6 | 152 | 0.000299 | 0.00224 |
622 | VENTRICULAR SEPTUM DEVELOPMENT | 4 | 54 | 0.0002995 | 0.00224 |
623 | DEPHOSPHORYLATION | 8 | 286 | 0.0003158 | 0.002359 |
624 | REGULATION OF KIDNEY DEVELOPMENT | 4 | 55 | 0.0003215 | 0.002397 |
625 | REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 218 | 0.0003312 | 0.002462 |
626 | POSITIVE REGULATION OF DEFENSE RESPONSE | 9 | 364 | 0.0003309 | 0.002462 |
627 | NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 3 | 23 | 0.0003334 | 0.002475 |
628 | HOMEOSTATIC PROCESS | 19 | 1337 | 0.0003377 | 0.002502 |
629 | SMAD PROTEIN SIGNAL TRANSDUCTION | 4 | 56 | 0.0003446 | 0.002541 |
630 | INOSITOL PHOSPHATE METABOLIC PROCESS | 4 | 56 | 0.0003446 | 0.002541 |
631 | REGULATION OF EXTENT OF CELL GROWTH | 5 | 101 | 0.0003443 | 0.002541 |
632 | MYOTUBE DIFFERENTIATION | 4 | 57 | 0.000369 | 0.002716 |
633 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 5 | 103 | 0.000377 | 0.002771 |
634 | POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 3 | 24 | 0.0003794 | 0.002776 |
635 | EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 3 | 24 | 0.0003794 | 0.002776 |
636 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 3 | 24 | 0.0003794 | 0.002776 |
637 | PROTEIN ACYLATION | 6 | 159 | 0.0003805 | 0.002779 |
638 | CELL PART MORPHOGENESIS | 12 | 633 | 0.0003951 | 0.002882 |
639 | REGENERATION | 6 | 161 | 0.0004067 | 0.002961 |
640 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 9 | 375 | 0.0004109 | 0.002988 |
641 | CEREBRAL CORTEX DEVELOPMENT | 5 | 105 | 0.0004119 | 0.00299 |
642 | VASCULOGENESIS | 4 | 59 | 0.0004212 | 0.003053 |
643 | SPINDLE CHECKPOINT | 3 | 25 | 0.0004293 | 0.003097 |
644 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 3 | 25 | 0.0004293 | 0.003097 |
645 | NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 3 | 25 | 0.0004293 | 0.003097 |
646 | CARDIAC VENTRICLE DEVELOPMENT | 5 | 106 | 0.0004303 | 0.003099 |
647 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 6 | 163 | 0.0004342 | 0.003123 |
648 | NEGATIVE REGULATION OF CELL DIVISION | 4 | 60 | 0.0004493 | 0.003226 |
649 | CELLULAR RESPONSE TO HORMONE STIMULUS | 11 | 552 | 0.0004595 | 0.003294 |
650 | ENDOMEMBRANE SYSTEM ORGANIZATION | 10 | 465 | 0.0004658 | 0.003335 |
651 | REGULATION OF CELL CYCLE ARREST | 5 | 108 | 0.0004688 | 0.003351 |
652 | REGULATION OF EPITHELIAL CELL MIGRATION | 6 | 166 | 0.0004783 | 0.003414 |
653 | DEVELOPMENTAL PROGRAMMED CELL DEATH | 3 | 26 | 0.0004832 | 0.003443 |
654 | POSITIVE REGULATION OF NUCLEAR DIVISION | 4 | 62 | 0.0005093 | 0.003623 |
655 | CELL CYCLE G1 S PHASE TRANSITION | 5 | 111 | 0.0005315 | 0.003764 |
656 | COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 5 | 111 | 0.0005315 | 0.003764 |
657 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 5 | 111 | 0.0005315 | 0.003764 |
658 | REGULATION OF PROTEIN SECRETION | 9 | 389 | 0.0005352 | 0.003785 |
659 | SKELETAL MUSCLE TISSUE REGENERATION | 3 | 27 | 0.0005413 | 0.003805 |
660 | NEGATIVE REGULATION OF AXON GUIDANCE | 3 | 27 | 0.0005413 | 0.003805 |
661 | RESPONSE TO LITHIUM ION | 3 | 27 | 0.0005413 | 0.003805 |
662 | NEUROEPITHELIAL CELL DIFFERENTIATION | 4 | 63 | 0.0005413 | 0.003805 |
663 | REGULATION OF PEPTIDASE ACTIVITY | 9 | 392 | 0.0005655 | 0.003969 |
664 | REGULATION OF CELL SIZE | 6 | 172 | 0.000577 | 0.004043 |
665 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 5 | 114 | 0.0006003 | 0.0042 |
666 | PLACENTA BLOOD VESSEL DEVELOPMENT | 3 | 28 | 0.0006036 | 0.004204 |
667 | NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 3 | 28 | 0.0006036 | 0.004204 |
668 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 3 | 28 | 0.0006036 | 0.004204 |
669 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 5 | 115 | 0.0006246 | 0.004331 |
670 | RESPONSE TO INTERLEUKIN 1 | 5 | 115 | 0.0006246 | 0.004331 |
671 | CELLULAR RESPONSE TO ALCOHOL | 5 | 115 | 0.0006246 | 0.004331 |
672 | REGULATION OF MICROTUBULE BASED PROCESS | 7 | 243 | 0.0006335 | 0.004386 |
673 | FEMALE SEX DIFFERENTIATION | 5 | 116 | 0.0006497 | 0.004492 |
674 | MULTICELLULAR ORGANISM REPRODUCTION | 13 | 768 | 0.0006573 | 0.004537 |
675 | REGULATION OF MEIOTIC NUCLEAR DIVISION | 3 | 29 | 0.0006703 | 0.004609 |
676 | MITOCHONDRIAL TRANSPORT | 6 | 177 | 0.0006706 | 0.004609 |
677 | NEUROBLAST PROLIFERATION | 3 | 29 | 0.0006703 | 0.004609 |
678 | NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT | 5 | 117 | 0.0006755 | 0.004636 |
679 | PROTEIN CATABOLIC PROCESS | 11 | 579 | 0.0006826 | 0.004659 |
680 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 4 | 67 | 0.0006839 | 0.004659 |
681 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 4 | 67 | 0.0006839 | 0.004659 |
682 | CELLULAR RESPONSE TO DRUG | 4 | 67 | 0.0006839 | 0.004659 |
683 | REGULATION OF SISTER CHROMATID SEGREGATION | 4 | 67 | 0.0006839 | 0.004659 |
684 | CHEMICAL HOMEOSTASIS | 14 | 874 | 0.0006972 | 0.004743 |
685 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 68 | 0.0007234 | 0.004907 |
686 | POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 4 | 68 | 0.0007234 | 0.004907 |
687 | REGULATION OF CHEMOTAXIS | 6 | 180 | 0.0007322 | 0.004959 |
688 | ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY | 3 | 30 | 0.0007416 | 0.004986 |
689 | POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 30 | 0.0007416 | 0.004986 |
690 | NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 3 | 30 | 0.0007416 | 0.004986 |
691 | RESPONSE TO X RAY | 3 | 30 | 0.0007416 | 0.004986 |
692 | MYOTUBE CELL DEVELOPMENT | 3 | 30 | 0.0007416 | 0.004986 |
693 | REGULATION OF DENDRITE DEVELOPMENT | 5 | 120 | 0.0007575 | 0.005086 |
694 | NEGATIVE REGULATION OF OSSIFICATION | 4 | 69 | 0.0007644 | 0.005125 |
695 | RESPONSE TO KETONE | 6 | 182 | 0.0007757 | 0.005193 |
696 | RESPONSE TO STEROID HORMONE | 10 | 497 | 0.0007783 | 0.005203 |
697 | PROTEOLYSIS | 17 | 1208 | 0.000797 | 0.00532 |
698 | REGULATION OF MYELOID CELL DIFFERENTIATION | 6 | 183 | 0.0007981 | 0.00532 |
699 | EPIDERMIS DEVELOPMENT | 7 | 253 | 0.000803 | 0.005345 |
700 | MUSCLE ORGAN MORPHOGENESIS | 4 | 70 | 0.000807 | 0.005349 |
701 | INTERFERON GAMMA MEDIATED SIGNALING PATHWAY | 4 | 70 | 0.000807 | 0.005349 |
702 | REGULATION OF MEMBRANE PERMEABILITY | 4 | 70 | 0.000807 | 0.005349 |
703 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 5 | 122 | 0.0008162 | 0.005395 |
704 | CELLULAR RESPONSE TO INTERFERON GAMMA | 5 | 122 | 0.0008162 | 0.005395 |
705 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 12 | 689 | 0.000834 | 0.005504 |
706 | CELL JUNCTION ORGANIZATION | 6 | 185 | 0.0008445 | 0.005566 |
707 | SKIN EPIDERMIS DEVELOPMENT | 4 | 71 | 0.0008513 | 0.005587 |
708 | ENDODERM DEVELOPMENT | 4 | 71 | 0.0008513 | 0.005587 |
709 | CELL FATE SPECIFICATION | 4 | 71 | 0.0008513 | 0.005587 |
710 | ENDOTHELIAL CELL DIFFERENTIATION | 4 | 72 | 0.0008973 | 0.005853 |
711 | EMBRYONIC FORELIMB MORPHOGENESIS | 3 | 32 | 0.0008982 | 0.005853 |
712 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 3 | 32 | 0.0008982 | 0.005853 |
713 | POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 3 | 32 | 0.0008982 | 0.005853 |
714 | ADIPOSE TISSUE DEVELOPMENT | 3 | 32 | 0.0008982 | 0.005853 |
715 | REGULATION OF SYSTEM PROCESS | 10 | 507 | 0.0009055 | 0.005893 |
716 | PANCREAS DEVELOPMENT | 4 | 73 | 0.000945 | 0.006141 |
717 | REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 33 | 0.0009837 | 0.006375 |
718 | EMBRYONIC EYE MORPHOGENESIS | 3 | 33 | 0.0009837 | 0.006375 |
719 | REGULATION OF DENDRITE MORPHOGENESIS | 4 | 74 | 0.0009944 | 0.006409 |
720 | CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 4 | 74 | 0.0009944 | 0.006409 |
721 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 74 | 0.0009944 | 0.006409 |
722 | CELL CELL JUNCTION ASSEMBLY | 4 | 74 | 0.0009944 | 0.006409 |
723 | PROTEIN ACETYLATION | 5 | 129 | 0.001049 | 0.006749 |
724 | FOREBRAIN NEURON DEVELOPMENT | 3 | 34 | 0.001074 | 0.006885 |
725 | REGULATION OF PROTEIN DEACETYLATION | 3 | 34 | 0.001074 | 0.006885 |
726 | NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 3 | 34 | 0.001074 | 0.006885 |
727 | DIENCEPHALON DEVELOPMENT | 4 | 77 | 0.001154 | 0.007384 |
728 | POSITIVE REGULATION OF CELL DIVISION | 5 | 132 | 0.001162 | 0.007427 |
729 | RESPONSE TO MINERALOCORTICOID | 3 | 35 | 0.00117 | 0.007457 |
730 | EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 3 | 35 | 0.00117 | 0.007457 |
731 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 14 | 926 | 0.001215 | 0.007736 |
732 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 8 | 352 | 0.001226 | 0.00779 |
733 | T CELL PROLIFERATION | 3 | 36 | 0.001271 | 0.008034 |
734 | POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 3 | 36 | 0.001271 | 0.008034 |
735 | POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 36 | 0.001271 | 0.008034 |
736 | HEAD MORPHOGENESIS | 3 | 36 | 0.001271 | 0.008034 |
737 | MUSCLE TISSUE DEVELOPMENT | 7 | 275 | 0.001302 | 0.008222 |
738 | NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 5 | 136 | 0.001327 | 0.008363 |
739 | NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 4 | 80 | 0.00133 | 0.008363 |
740 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 4 | 80 | 0.00133 | 0.008363 |
741 | ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY | 3 | 37 | 0.001377 | 0.008634 |
742 | ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 3 | 37 | 0.001377 | 0.008634 |
743 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 4 | 81 | 0.001393 | 0.00871 |
744 | NUCLEAR ENVELOPE ORGANIZATION | 4 | 81 | 0.001393 | 0.00871 |
745 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 7 | 279 | 0.001415 | 0.008836 |
746 | REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 7 | 280 | 0.001444 | 0.009007 |
747 | NEGATIVE REGULATION OF AXON EXTENSION | 3 | 38 | 0.001488 | 0.009223 |
748 | ACTIN FILAMENT BASED PROCESS | 9 | 450 | 0.001489 | 0.009223 |
749 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 3 | 38 | 0.001488 | 0.009223 |
750 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 3 | 38 | 0.001488 | 0.009223 |
751 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 38 | 0.001488 | 0.009223 |
752 | HAIR CYCLE | 4 | 83 | 0.001524 | 0.009407 |
753 | NIK NF KAPPAB SIGNALING | 4 | 83 | 0.001524 | 0.009407 |
754 | MOLTING CYCLE | 4 | 83 | 0.001524 | 0.009407 |
755 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 4 | 84 | 0.001593 | 0.009819 |
756 | POSITIVE REGULATION OF VIRAL TRANSCRIPTION | 3 | 39 | 0.001606 | 0.009856 |
757 | REGULATION OF AXON GUIDANCE | 3 | 39 | 0.001606 | 0.009856 |
758 | TRABECULA MORPHOGENESIS | 3 | 39 | 0.001606 | 0.009856 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | FRIZZLED BINDING | 19 | 36 | 9.11e-34 | 8.463e-31 |
2 | BETA CATENIN BINDING | 20 | 84 | 4.56e-27 | 2.118e-24 |
3 | WNT ACTIVATED RECEPTOR ACTIVITY | 14 | 22 | 9.717e-27 | 3.009e-24 |
4 | WNT PROTEIN BINDING | 15 | 31 | 4.615e-26 | 1.072e-23 |
5 | G PROTEIN COUPLED RECEPTOR BINDING | 19 | 259 | 1.085e-15 | 2.015e-13 |
6 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 23 | 445 | 1.687e-15 | 2.612e-13 |
7 | RECEPTOR AGONIST ACTIVITY | 8 | 16 | 1.53e-14 | 2.031e-12 |
8 | PROTEIN KINASE ACTIVITY | 24 | 640 | 4.363e-13 | 5.067e-11 |
9 | ENZYME BINDING | 38 | 1737 | 5.407e-13 | 5.582e-11 |
10 | TRANSCRIPTION FACTOR BINDING | 21 | 524 | 4.376e-12 | 4.065e-10 |
11 | SIGNAL TRANSDUCER ACTIVITY | 36 | 1731 | 1.179e-11 | 9.124e-10 |
12 | RECEPTOR ACTIVATOR ACTIVITY | 8 | 32 | 1.155e-11 | 9.124e-10 |
13 | RECEPTOR BINDING | 33 | 1476 | 1.625e-11 | 1.161e-09 |
14 | PROTEIN DOMAIN SPECIFIC BINDING | 21 | 624 | 1.134e-10 | 7.523e-09 |
15 | KINASE ACTIVITY | 24 | 842 | 1.355e-10 | 8.389e-09 |
16 | MOLECULAR FUNCTION REGULATOR | 30 | 1353 | 2.111e-10 | 1.213e-08 |
17 | RECEPTOR REGULATOR ACTIVITY | 8 | 45 | 2.22e-10 | 1.213e-08 |
18 | REGULATORY REGION NUCLEIC ACID BINDING | 22 | 818 | 2.615e-09 | 1.35e-07 |
19 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 24 | 992 | 3.578e-09 | 1.749e-07 |
20 | ARMADILLO REPEAT DOMAIN BINDING | 5 | 13 | 8.489e-09 | 3.943e-07 |
21 | KINASE BINDING | 18 | 606 | 1.934e-08 | 8.556e-07 |
22 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 14 | 371 | 4.545e-08 | 1.919e-06 |
23 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 12 | 264 | 5.918e-08 | 2.39e-06 |
24 | PDZ DOMAIN BINDING | 8 | 90 | 6.392e-08 | 2.474e-06 |
25 | PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY | 5 | 21 | 1.292e-07 | 4.802e-06 |
26 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 17 | 629 | 1.921e-07 | 6.82e-06 |
27 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 8 | 104 | 1.982e-07 | 6.82e-06 |
28 | SMAD BINDING | 7 | 72 | 2.364e-07 | 7.844e-06 |
29 | PROTEIN DIMERIZATION ACTIVITY | 23 | 1149 | 2.528e-07 | 8.097e-06 |
30 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 12 | 315 | 3.986e-07 | 1.234e-05 |
31 | GAMMA CATENIN BINDING | 4 | 12 | 5.684e-07 | 1.703e-05 |
32 | MAP KINASE ACTIVITY | 4 | 14 | 1.139e-06 | 3.307e-05 |
33 | CALMODULIN BINDING | 9 | 179 | 1.252e-06 | 3.525e-05 |
34 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 15 | 588 | 2.189e-06 | 5.982e-05 |
35 | RIBONUCLEOTIDE BINDING | 28 | 1860 | 3.307e-06 | 8.777e-05 |
36 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 11 | 328 | 4.26e-06 | 0.0001099 |
37 | ADENYL NUCLEOTIDE BINDING | 24 | 1514 | 8.203e-06 | 0.000206 |
38 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 9 | 226 | 8.443e-06 | 0.0002064 |
39 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 8 | 172 | 8.861e-06 | 0.0002111 |
40 | R SMAD BINDING | 4 | 23 | 9.667e-06 | 0.0002245 |
41 | SEQUENCE SPECIFIC DNA BINDING | 19 | 1037 | 1.147e-05 | 0.0002599 |
42 | PHOSPHATASE REGULATOR ACTIVITY | 6 | 87 | 1.333e-05 | 0.0002947 |
43 | ENZYME REGULATOR ACTIVITY | 18 | 959 | 1.452e-05 | 0.0003138 |
44 | CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 28 | 2.184e-05 | 0.0004612 |
45 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 57 | 2.241e-05 | 0.0004627 |
46 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 20 | 1199 | 2.561e-05 | 0.0005171 |
47 | I SMAD BINDING | 3 | 11 | 3.273e-05 | 0.0006408 |
48 | PHOSPHOLIPASE C ACTIVITY | 4 | 31 | 3.311e-05 | 0.0006408 |
49 | PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 5 | 64 | 3.948e-05 | 0.0007485 |
50 | CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 12 | 4.345e-05 | 0.0008073 |
51 | DOUBLE STRANDED DNA BINDING | 15 | 764 | 4.837e-05 | 0.0008811 |
52 | CHROMATIN BINDING | 11 | 435 | 5.824e-05 | 0.00104 |
53 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 4 | 36 | 6.058e-05 | 0.001062 |
54 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 10 | 368 | 7.078e-05 | 0.001196 |
55 | TRANSCRIPTION COACTIVATOR ACTIVITY | 9 | 296 | 7.037e-05 | 0.001196 |
56 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 3 | 15 | 8.87e-05 | 0.001471 |
57 | PROTEIN HOMODIMERIZATION ACTIVITY | 14 | 722 | 0.0001003 | 0.001634 |
58 | RHO GTPASE BINDING | 5 | 78 | 0.0001023 | 0.001639 |
59 | PROTEIN KINASE C ACTIVITY | 3 | 16 | 0.0001087 | 0.001711 |
60 | PROTEIN HETERODIMERIZATION ACTIVITY | 11 | 468 | 0.0001115 | 0.001726 |
61 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 5 | 92 | 0.0002231 | 0.003397 |
62 | ENHANCER BINDING | 5 | 93 | 0.0002346 | 0.003516 |
63 | MITOGEN ACTIVATED PROTEIN KINASE BINDING | 3 | 24 | 0.0003794 | 0.005595 |
64 | DRUG BINDING | 5 | 109 | 0.0004891 | 0.007099 |
65 | TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 6 | 168 | 0.0005096 | 0.007284 |
66 | MACROMOLECULAR COMPLEX BINDING | 19 | 1399 | 0.0005907 | 0.008314 |
67 | BHLH TRANSCRIPTION FACTOR BINDING | 3 | 28 | 0.0006036 | 0.008369 |
68 | PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 6 | 178 | 0.0006907 | 0.009299 |
69 | P53 BINDING | 4 | 67 | 0.0006839 | 0.009299 |
70 | NF KAPPAB BINDING | 3 | 30 | 0.0007416 | 0.009842 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | WNT SIGNALOSOME | 8 | 11 | 2.011e-16 | 1.174e-13 |
2 | BETA CATENIN DESTRUCTION COMPLEX | 8 | 14 | 3.606e-15 | 1.053e-12 |
3 | PHOSPHATASE COMPLEX | 10 | 48 | 2.046e-13 | 3.984e-11 |
4 | ENDOCYTIC VESICLE MEMBRANE | 14 | 152 | 3.484e-13 | 5.086e-11 |
5 | PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 7 | 20 | 1.606e-11 | 1.876e-09 |
6 | CATALYTIC COMPLEX | 27 | 1038 | 6.115e-11 | 5.952e-09 |
7 | ENDOCYTIC VESICLE | 14 | 256 | 3.976e-10 | 2.903e-08 |
8 | PROTEINACEOUS EXTRACELLULAR MATRIX | 16 | 356 | 3.707e-10 | 2.903e-08 |
9 | EXTRACELLULAR MATRIX | 17 | 426 | 6.213e-10 | 4.031e-08 |
10 | CHROMOSOME | 22 | 880 | 9.885e-09 | 5.773e-07 |
11 | NUCLEAR CHROMATIN | 13 | 291 | 1.976e-08 | 1.049e-06 |
12 | TRANSCRIPTION FACTOR COMPLEX | 13 | 298 | 2.616e-08 | 1.273e-06 |
13 | CHROMATIN | 15 | 441 | 5.701e-08 | 2.561e-06 |
14 | VESICLE MEMBRANE | 15 | 512 | 3.895e-07 | 1.625e-05 |
15 | SYNAPSE | 18 | 754 | 5.029e-07 | 1.944e-05 |
16 | CELL SURFACE | 18 | 757 | 5.327e-07 | 1.944e-05 |
17 | GOLGI LUMEN | 7 | 94 | 1.475e-06 | 5.067e-05 |
18 | CYTOPLASMIC VESICLE PART | 15 | 601 | 2.861e-06 | 9.281e-05 |
19 | INTRACELLULAR VESICLE | 22 | 1259 | 4.52e-06 | 0.0001389 |
20 | TRANSCRIPTIONAL REPRESSOR COMPLEX | 6 | 74 | 5.205e-06 | 0.000152 |
21 | NUCLEAR CHROMOSOME | 13 | 523 | 1.438e-05 | 0.0003998 |
22 | PROTEIN KINASE COMPLEX | 6 | 90 | 1.619e-05 | 0.0004299 |
23 | SCF UBIQUITIN LIGASE COMPLEX | 4 | 34 | 4.813e-05 | 0.001222 |
24 | SYNAPSE PART | 13 | 610 | 7.042e-05 | 0.001714 |
25 | TRANSFERASE COMPLEX | 14 | 703 | 7.561e-05 | 0.001726 |
26 | LAMELLIPODIUM | 7 | 172 | 7.684e-05 | 0.001726 |
27 | CHROMOSOME CENTROMERIC REGION | 7 | 174 | 8.262e-05 | 0.001787 |
28 | CYTOSKELETAL PART | 21 | 1436 | 0.0001057 | 0.002206 |
29 | NUCLEAR TRANSCRIPTION FACTOR COMPLEX | 6 | 127 | 0.0001125 | 0.002265 |
30 | NUCLEAR ENVELOPE | 10 | 416 | 0.0001928 | 0.003472 |
31 | MICROTUBULE CYTOSKELETON | 17 | 1068 | 0.0001941 | 0.003472 |
32 | EXCITATORY SYNAPSE | 7 | 197 | 0.0001787 | 0.003472 |
33 | CYTOSKELETON | 25 | 1967 | 2e-04 | 0.003472 |
34 | ENDOPLASMIC RETICULUM LUMEN | 7 | 201 | 0.0002021 | 0.003472 |
35 | LATERAL PLASMA MEMBRANE | 4 | 50 | 0.0002221 | 0.003706 |
36 | NEURONAL POSTSYNAPTIC DENSITY | 4 | 53 | 0.0002786 | 0.004397 |
37 | NUCLEAR MEMBRANE | 8 | 280 | 0.0002739 | 0.004397 |
38 | NUCLEOPLASM PART | 13 | 708 | 0.0003052 | 0.00469 |
39 | MICROTUBULE ORGANIZING CENTER | 12 | 623 | 0.0003425 | 0.005129 |
40 | EXTRACELLULAR SPACE | 19 | 1376 | 0.0004823 | 0.007041 |
41 | CENTROSOME | 10 | 487 | 0.0006661 | 0.009488 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04310_Wnt_signaling_pathway | 119 | 151 | 7.013e-283 | 1.262e-280 | |
2 | hsa04916_Melanogenesis | 45 | 101 | 4.55e-76 | 4.095e-74 | |
3 | hsa04390_Hippo_signaling_pathway | 45 | 154 | 6.052e-66 | 3.631e-64 | |
4 | hsa04340_Hedgehog_signaling_pathway | 22 | 56 | 2.556e-35 | 1.15e-33 | |
5 | hsa04720_Long.term_potentiation | 19 | 70 | 5.72e-27 | 2.059e-25 | |
6 | hsa04114_Oocyte_meiosis | 20 | 114 | 3.542e-24 | 1.063e-22 | |
7 | hsa04520_Adherens_junction | 17 | 73 | 6.005e-23 | 1.544e-21 | |
8 | hsa04912_GnRH_signaling_pathway | 17 | 101 | 2.372e-20 | 5.337e-19 | |
9 | hsa04010_MAPK_signaling_pathway | 21 | 268 | 7.623e-18 | 1.525e-16 | |
10 | hsa04971_Gastric_acid_secretion | 14 | 74 | 1.073e-17 | 1.931e-16 | |
11 | hsa04662_B_cell_receptor_signaling_pathway | 14 | 75 | 1.313e-17 | 2.148e-16 | |
12 | hsa04370_VEGF_signaling_pathway | 14 | 76 | 1.601e-17 | 2.402e-16 | |
13 | hsa04020_Calcium_signaling_pathway | 17 | 177 | 4.285e-16 | 5.934e-15 | |
14 | hsa04360_Axon_guidance | 15 | 130 | 1.598e-15 | 2.055e-14 | |
15 | hsa04350_TGF.beta_signaling_pathway | 13 | 85 | 3.085e-15 | 3.702e-14 | |
16 | hsa04510_Focal_adhesion | 17 | 200 | 3.359e-15 | 3.779e-14 | |
17 | hsa04012_ErbB_signaling_pathway | 13 | 87 | 4.231e-15 | 4.48e-14 | |
18 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 14 | 136 | 7.368e-14 | 7.271e-13 | |
19 | hsa04660_T_cell_receptor_signaling_pathway | 13 | 108 | 7.675e-14 | 7.271e-13 | |
20 | hsa04270_Vascular_smooth_muscle_contraction | 13 | 116 | 1.971e-13 | 1.774e-12 | |
21 | hsa04062_Chemokine_signaling_pathway | 14 | 189 | 6.937e-12 | 5.946e-11 | |
22 | hsa04722_Neurotrophin_signaling_pathway | 12 | 127 | 1.353e-11 | 1.107e-10 | |
23 | hsa04110_Cell_cycle | 12 | 128 | 1.486e-11 | 1.163e-10 | |
24 | hsa04970_Salivary_secretion | 10 | 89 | 1.298e-10 | 9.732e-10 | |
25 | hsa04540_Gap_junction | 10 | 90 | 1.453e-10 | 1.046e-09 | |
26 | hsa04380_Osteoclast_differentiation | 11 | 128 | 2.804e-10 | 1.941e-09 | |
27 | hsa04730_Long.term_depression | 9 | 70 | 3.299e-10 | 2.2e-09 | |
28 | hsa04972_Pancreatic_secretion | 9 | 101 | 9.085e-09 | 5.84e-08 | |
29 | hsa04014_Ras_signaling_pathway | 12 | 236 | 1.718e-08 | 1.066e-07 | |
30 | hsa04664_Fc_epsilon_RI_signaling_pathway | 8 | 79 | 2.272e-08 | 1.363e-07 | |
31 | hsa04151_PI3K_AKT_signaling_pathway | 13 | 351 | 1.759e-07 | 1.021e-06 | |
32 | hsa04710_Circadian_rhythm_._mammal | 5 | 23 | 2.116e-07 | 1.191e-06 | |
33 | hsa04070_Phosphatidylinositol_signaling_system | 7 | 78 | 4.117e-07 | 2.246e-06 | |
34 | hsa04670_Leukocyte_transendothelial_migration | 8 | 117 | 4.922e-07 | 2.606e-06 | |
35 | hsa04530_Tight_junction | 8 | 133 | 1.307e-06 | 6.72e-06 | |
36 | hsa04330_Notch_signaling_pathway | 5 | 47 | 8.609e-06 | 4.304e-05 | |
37 | hsa03015_mRNA_surveillance_pathway | 6 | 83 | 1.015e-05 | 4.94e-05 | |
38 | hsa04914_Progesterone.mediated_oocyte_maturation | 6 | 87 | 1.333e-05 | 6.312e-05 | |
39 | hsa04210_Apoptosis | 6 | 89 | 1.519e-05 | 7.009e-05 | |
40 | hsa04910_Insulin_signaling_pathway | 7 | 138 | 1.882e-05 | 8.47e-05 | |
41 | hsa04620_Toll.like_receptor_signaling_pathway | 6 | 102 | 3.305e-05 | 0.0001451 | |
42 | hsa04810_Regulation_of_actin_cytoskeleton | 8 | 214 | 4.275e-05 | 0.0001832 | |
43 | hsa04742_Taste_transduction | 4 | 52 | 0.0002587 | 0.00106 | |
44 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 5 | 95 | 0.0002591 | 0.00106 | |
45 | hsa04630_Jak.STAT_signaling_pathway | 6 | 155 | 0.000332 | 0.001328 | |
46 | hsa00562_Inositol_phosphate_metabolism | 4 | 57 | 0.000369 | 0.001444 | |
47 | hsa04621_NOD.like_receptor_signaling_pathway | 4 | 59 | 0.0004212 | 0.001613 | |
48 | hsa04115_p53_signaling_pathway | 4 | 69 | 0.0007644 | 0.002866 | |
49 | hsa04622_RIG.I.like_receptor_signaling_pathway | 4 | 71 | 0.0008513 | 0.003127 | |
50 | hsa04120_Ubiquitin_mediated_proteolysis | 5 | 139 | 0.001462 | 0.005262 | |
51 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 3 | 42 | 0.001991 | 0.007027 | |
52 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.002277 | 0.007882 | |
53 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 5 | 168 | 0.003333 | 0.01132 | |
54 | hsa04920_Adipocytokine_signaling_pathway | 3 | 68 | 0.007771 | 0.0259 | |
55 | hsa04740_Olfactory_transduction | 7 | 388 | 0.008584 | 0.02809 | |
56 | hsa04976_Bile_secretion | 3 | 71 | 0.00875 | 0.02812 | |
57 | hsa04973_Carbohydrate_digestion_and_absorption | 2 | 44 | 0.02823 | 0.08914 | |
58 | hsa03008_Ribosome_biogenesis_in_eukaryotes | 2 | 81 | 0.084 | 0.2607 | |
59 | hsa04144_Endocytosis | 3 | 203 | 0.1208 | 0.3686 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MEG3 |
hsa-miR-1254;hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-185-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-429;hsa-miR-532-5p;hsa-miR-625-5p;hsa-miR-629-3p | 11 | NFATC4 | Sponge network | -1.645 | 0.00049 | -0.981 | 0.00292 | 0.5 |
2 | MEG3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-224-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-592;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 30 | PRICKLE2 | Sponge network | -1.645 | 0.00049 | -2.154 | 0 | 0.479 |
3 | AGAP11 |
hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-140-5p;hsa-miR-142-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-362-3p;hsa-miR-3662;hsa-miR-500a-3p;hsa-miR-576-5p | 20 | DAAM1 | Sponge network | -1.728 | 0.00016 | -0.57 | 0.03626 | 0.478 |
4 | DGCR5 |
hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-140-3p;hsa-miR-186-5p;hsa-miR-2110;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-335-5p;hsa-miR-3614-5p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-5p | 13 | VANGL2 | Sponge network | 1.383 | 0.01835 | -0.012 | 0.98605 | 0.466 |
5 | CASC2 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-100-5p;hsa-miR-146b-3p;hsa-miR-149-5p;hsa-miR-181a-2-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-296-5p;hsa-miR-342-3p;hsa-miR-369-3p;hsa-miR-409-3p;hsa-miR-493-5p;hsa-miR-744-3p | 16 | FZD5 | Sponge network | -0.561 | 0.05962 | -0.562 | 0.20161 | 0.462 |
6 | PLAC4 |
hsa-let-7a-3p;hsa-miR-100-5p;hsa-miR-149-5p;hsa-miR-181a-2-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-296-5p;hsa-miR-455-5p;hsa-miR-744-3p | 10 | FZD5 | Sponge network | -0.563 | 0.27163 | -0.562 | 0.20161 | 0.457 |
7 | KCNQ1OT1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-100-5p;hsa-miR-149-5p;hsa-miR-181a-2-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-296-5p;hsa-miR-744-3p;hsa-miR-9-5p;hsa-miR-99a-5p | 12 | FZD5 | Sponge network | -0.725 | 0.08874 | -0.562 | 0.20161 | 0.449 |
8 | CASC2 |
hsa-miR-142-5p;hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-214-3p;hsa-miR-218-5p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-24-2-5p;hsa-miR-369-3p;hsa-miR-374a-3p;hsa-miR-452-5p;hsa-miR-654-3p;hsa-miR-944 | 15 | PRKCA | Sponge network | -0.561 | 0.05962 | -0.525 | 0.15685 | 0.436 |
9 | AGAP11 |
hsa-miR-107;hsa-miR-126-5p;hsa-miR-148a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-2110;hsa-miR-29a-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-501-3p;hsa-miR-502-3p | 13 | CSNK1A1 | Sponge network | -1.728 | 0.00016 | -0.125 | 0.51313 | 0.433 |
10 | KCNQ1OT1 |
hsa-miR-127-3p;hsa-miR-182-5p;hsa-miR-193b-5p;hsa-miR-218-5p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-27b-5p;hsa-miR-452-5p;hsa-miR-9-5p | 10 | NFATC2 | Sponge network | -0.725 | 0.08874 | -1.6 | 0.00281 | 0.425 |
11 | EMX2OS |
hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 28 | PRICKLE2 | Sponge network | -1.088 | 0.10042 | -2.154 | 0 | 0.415 |
12 | KCNQ1OT1 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 11 | NLK | Sponge network | -0.725 | 0.08874 | 0.087 | 0.60941 | 0.392 |
13 | PCA3 |
hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-452-3p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p | 13 | PRKCB | Sponge network | -2.778 | 8.0E-5 | -1.403 | 0.00367 | 0.387 |
14 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-219a-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-708-5p;hsa-miR-940 | 34 | FZD4 | Sponge network | -2.778 | 8.0E-5 | -1.774 | 0 | 0.38 |
15 | MEG3 |
hsa-miR-130b-5p;hsa-miR-15b-3p;hsa-miR-185-5p;hsa-miR-19b-1-5p;hsa-miR-25-3p;hsa-miR-320c;hsa-miR-331-3p;hsa-miR-335-5p;hsa-miR-3614-5p;hsa-miR-429;hsa-miR-616-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-939-5p | 14 | CAMK2A | Sponge network | -1.645 | 0.00049 | -0.131 | 0.82753 | 0.374 |
16 | PCA3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-221-5p;hsa-miR-224-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-3662;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-589-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-629-3p;hsa-miR-7-1-3p | 34 | PRICKLE2 | Sponge network | -2.778 | 8.0E-5 | -2.154 | 0 | 0.374 |
17 | PART1 |
hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-186-5p;hsa-miR-196a-5p;hsa-miR-2110;hsa-miR-335-5p;hsa-miR-3614-5p;hsa-miR-362-5p;hsa-miR-501-5p;hsa-miR-7-1-3p | 12 | VANGL2 | Sponge network | -2.298 | 0.00168 | -0.012 | 0.98605 | 0.367 |
18 | CASC2 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-342-3p | 11 | NLK | Sponge network | -0.561 | 0.05962 | 0.087 | 0.60941 | 0.352 |
19 | DGCR5 |
hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-215-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p;hsa-miR-577 | 11 | FZD1 | Sponge network | 1.383 | 0.01835 | -0.012 | 0.97106 | 0.349 |
20 | PCA3 |
hsa-miR-130b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-193b-5p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-27b-5p;hsa-miR-33a-3p;hsa-miR-3613-5p;hsa-miR-590-3p | 12 | NFATC2 | Sponge network | -2.778 | 8.0E-5 | -1.6 | 0.00281 | 0.343 |
21 | HCG18 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-100-5p;hsa-miR-146b-3p;hsa-miR-149-5p;hsa-miR-181a-2-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-342-3p;hsa-miR-409-3p;hsa-miR-455-5p;hsa-miR-493-5p | 14 | FZD5 | Sponge network | -0.24 | 0.23472 | -0.562 | 0.20161 | 0.338 |
22 | MALAT1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-629-3p;hsa-miR-92b-3p;hsa-miR-940 | 20 | FZD4 | Sponge network | -1.099 | 0.0005 | -1.774 | 0 | 0.338 |
23 | MEG3 |
hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-96-5p | 12 | SFRP1 | Sponge network | -1.645 | 0.00049 | -3.737 | 0.00012 | 0.336 |
24 | HCG18 |
hsa-miR-127-3p;hsa-miR-16-2-3p;hsa-miR-193b-5p;hsa-miR-214-3p;hsa-miR-218-5p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-27b-5p;hsa-miR-452-5p;hsa-miR-493-5p | 11 | NFATC2 | Sponge network | -0.24 | 0.23472 | -1.6 | 0.00281 | 0.333 |
25 | AGAP11 |
hsa-let-7f-1-3p;hsa-miR-130b-5p;hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-326;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-3662;hsa-miR-421;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-629-3p | 25 | PRICKLE2 | Sponge network | -1.728 | 0.00016 | -2.154 | 0 | 0.332 |
26 | KCNQ1OT1 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-708-5p | 11 | FZD4 | Sponge network | -0.725 | 0.08874 | -1.774 | 0 | 0.329 |
27 | DGCR5 |
hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-186-5p;hsa-miR-2110;hsa-miR-26a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-326;hsa-miR-375;hsa-miR-577 | 11 | WNT5A | Sponge network | 1.383 | 0.01835 | 1.419 | 0.00302 | 0.327 |
28 | MAP3K14 | hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-629-3p;hsa-miR-708-5p | 11 | FZD4 | Sponge network | -0.259 | 0.26796 | -1.774 | 0 | 0.323 |
29 | PCA3 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-181a-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-301a-3p;hsa-miR-3065-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-424-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-708-5p;hsa-miR-93-5p;hsa-miR-96-5p | 30 | CCND2 | Sponge network | -2.778 | 8.0E-5 | -0.496 | 0.3 | 0.318 |
30 | RFPL1S |
hsa-miR-148a-5p;hsa-miR-186-5p;hsa-miR-2110;hsa-miR-26b-5p;hsa-miR-29a-5p;hsa-miR-30d-3p;hsa-miR-326;hsa-miR-330-5p;hsa-miR-375;hsa-miR-7-1-3p | 10 | WNT5A | Sponge network | -0.223 | 0.70704 | 1.419 | 0.00302 | 0.317 |
31 | MALAT1 |
hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-24-3p;hsa-miR-33a-5p;hsa-miR-424-3p | 10 | NFAT5 | Sponge network | -1.099 | 0.0005 | -0.044 | 0.82158 | 0.315 |
32 | KCNQ1OT1 |
hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-218-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-374a-3p;hsa-miR-452-5p;hsa-miR-654-3p;hsa-miR-9-3p;hsa-miR-9-5p;hsa-miR-944 | 12 | PRKCA | Sponge network | -0.725 | 0.08874 | -0.525 | 0.15685 | 0.313 |
33 | AGAP11 |
hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-140-3p;hsa-miR-196a-5p;hsa-miR-2110;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-5p | 10 | VANGL2 | Sponge network | -1.728 | 0.00016 | -0.012 | 0.98605 | 0.313 |
34 | RFPL1S |
hsa-miR-144-3p;hsa-miR-148a-3p;hsa-miR-148b-5p;hsa-miR-19b-1-5p;hsa-miR-26b-5p;hsa-miR-320c;hsa-miR-335-5p;hsa-miR-338-3p;hsa-miR-3614-5p;hsa-miR-429;hsa-miR-625-5p;hsa-miR-7-1-3p;hsa-miR-92a-3p;hsa-miR-939-5p | 14 | CAMK2A | Sponge network | -0.223 | 0.70704 | -0.131 | 0.82753 | 0.31 |
35 | FAM95B1 |
hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-193b-5p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-31-3p;hsa-miR-452-5p;hsa-miR-484 | 10 | NFATC2 | Sponge network | -1.726 | 0.00466 | -1.6 | 0.00281 | 0.304 |
36 | MEG3 |
hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-224-3p;hsa-miR-25-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-455-3p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-629-3p | 25 | FZD4 | Sponge network | -1.645 | 0.00049 | -1.774 | 0 | 0.304 |
37 | PLAC4 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-125a-3p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p | 12 | NLK | Sponge network | -0.563 | 0.27163 | 0.087 | 0.60941 | 0.302 |
38 | MIAT |
hsa-let-7f-1-3p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-3065-5p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-326;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-592 | 13 | PRICKLE2 | Sponge network | 0.534 | 0.20962 | -2.154 | 0 | 0.293 |
39 | RFPL1S |
hsa-miR-146a-5p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-215-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-335-5p | 10 | FZD1 | Sponge network | -0.223 | 0.70704 | -0.012 | 0.97106 | 0.293 |
40 | RFPL1S |
hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-30b-3p;hsa-miR-30d-3p;hsa-miR-326;hsa-miR-330-5p;hsa-miR-362-3p;hsa-miR-429 | 10 | TCF7L1 | Sponge network | -0.223 | 0.70704 | -0.31 | 0.43474 | 0.289 |
41 | MALAT1 |
hsa-miR-127-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-185-5p;hsa-miR-193b-5p;hsa-miR-2355-3p;hsa-miR-2355-5p;hsa-miR-24-3p;hsa-miR-27b-5p;hsa-miR-452-5p | 10 | NFATC2 | Sponge network | -1.099 | 0.0005 | -1.6 | 0.00281 | 0.286 |
42 | HCG18 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-miR-152-3p;hsa-miR-199a-3p;hsa-miR-199b-3p;hsa-miR-23a-3p;hsa-miR-23b-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-342-3p | 12 | NLK | Sponge network | -0.24 | 0.23472 | 0.087 | 0.60941 | 0.285 |
43 | FAM66C |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-18a-5p;hsa-miR-197-3p;hsa-miR-19a-3p;hsa-miR-320b;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p | 15 | PRICKLE2 | Sponge network | -0.353 | 0.40349 | -2.154 | 0 | 0.284 |
44 | AGAP11 |
hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-126-5p;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-212-3p;hsa-miR-26b-3p;hsa-miR-320b;hsa-miR-424-5p | 14 | NFAT5 | Sponge network | -1.728 | 0.00016 | -0.044 | 0.82158 | 0.278 |
45 | PCA3 |
hsa-miR-130b-5p;hsa-miR-183-5p;hsa-miR-193b-3p;hsa-miR-193b-5p;hsa-miR-200c-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-2355-3p;hsa-miR-330-3p;hsa-miR-369-3p;hsa-miR-590-3p;hsa-miR-93-3p;hsa-miR-944 | 13 | PRKCA | Sponge network | -2.778 | 8.0E-5 | -0.525 | 0.15685 | 0.278 |
46 | PLAC4 |
hsa-let-7a-3p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-424-5p;hsa-miR-455-3p;hsa-miR-708-5p;hsa-miR-940 | 15 | FZD4 | Sponge network | -0.563 | 0.27163 | -1.774 | 0 | 0.277 |
47 | DGCR5 |
hsa-miR-107;hsa-miR-126-5p;hsa-miR-148a-5p;hsa-miR-186-5p;hsa-miR-2110;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-577;hsa-miR-592;hsa-miR-652-3p | 12 | CSNK1A1 | Sponge network | 1.383 | 0.01835 | -0.125 | 0.51313 | 0.276 |
48 | GHRLOS | hsa-let-7b-5p;hsa-let-7d-5p;hsa-miR-130b-3p;hsa-miR-15b-5p;hsa-miR-185-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-455-3p;hsa-miR-940 | 11 | FZD4 | Sponge network | -0.724 | 0.01784 | -1.774 | 0 | 0.275 |
49 | EMX2OS |
hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-181b-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-335-3p;hsa-miR-34a-5p;hsa-miR-362-3p;hsa-miR-500a-3p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-92b-3p | 21 | DAAM1 | Sponge network | -1.088 | 0.10042 | -0.57 | 0.03626 | 0.274 |
50 | HCG18 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-708-5p | 10 | FZD4 | Sponge network | -0.24 | 0.23472 | -1.774 | 0 | 0.274 |
51 | RFPL1S |
hsa-miR-146a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-181b-5p;hsa-miR-186-5p;hsa-miR-18a-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-5p;hsa-miR-320b;hsa-miR-320c;hsa-miR-326;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-576-5p;hsa-miR-589-5p;hsa-miR-7-1-3p | 22 | PRICKLE2 | Sponge network | -0.223 | 0.70704 | -2.154 | 0 | 0.273 |
52 | FAM66C |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-590-5p | 10 | PRKACB | Sponge network | -0.353 | 0.40349 | -2.003 | 0 | 0.273 |
53 | HAR1A |
hsa-let-7b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-181a-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-185-5p;hsa-miR-200a-3p;hsa-miR-21-3p;hsa-miR-224-3p;hsa-miR-320b;hsa-miR-324-3p;hsa-miR-33a-3p | 13 | CCND2 | Sponge network | -0.801 | 0.17598 | -0.496 | 0.3 | 0.272 |
54 | CASC2 |
hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-miR-224-3p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-324-3p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-708-5p;hsa-miR-940 | 12 | FZD4 | Sponge network | -0.561 | 0.05962 | -1.774 | 0 | 0.271 |
55 | AGAP11 |
hsa-let-7f-1-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-2110;hsa-miR-3662;hsa-miR-421;hsa-miR-590-5p;hsa-miR-93-5p | 10 | PRKACB | Sponge network | -1.728 | 0.00016 | -2.003 | 0 | 0.27 |
56 | FAM95B1 |
hsa-let-7a-3p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-21-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-324-3p;hsa-miR-424-5p;hsa-miR-452-5p;hsa-miR-455-3p;hsa-miR-484;hsa-miR-629-3p;hsa-miR-708-5p;hsa-miR-940 | 16 | FZD4 | Sponge network | -1.726 | 0.00466 | -1.774 | 0 | 0.268 |
57 | MEG3 |
hsa-let-7f-1-3p;hsa-miR-103a-3p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-148b-3p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-26b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-652-3p | 14 | NFAT5 | Sponge network | -1.645 | 0.00049 | -0.044 | 0.82158 | 0.265 |
58 | MEG3 |
hsa-miR-141-5p;hsa-miR-16-2-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-23a-3p;hsa-miR-335-3p;hsa-miR-361-5p;hsa-miR-429;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-9-3p | 11 | PRKCB | Sponge network | -1.645 | 0.00049 | -1.403 | 0.00367 | 0.265 |
59 | RFPL1S |
hsa-miR-192-3p;hsa-miR-19b-1-5p;hsa-miR-26b-3p;hsa-miR-29a-5p;hsa-miR-335-5p;hsa-miR-33a-3p;hsa-miR-3662;hsa-miR-429;hsa-miR-576-5p;hsa-miR-625-5p;hsa-miR-7-1-3p | 11 | SFRP1 | Sponge network | -0.223 | 0.70704 | -3.737 | 0.00012 | 0.261 |
60 | PCA3 |
hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-146b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-200c-3p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-3662;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-93-5p;hsa-miR-96-5p | 17 | PRKACB | Sponge network | -2.778 | 8.0E-5 | -2.003 | 0 | 0.257 |
61 | PART1 |
hsa-miR-107;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-2110;hsa-miR-29a-5p;hsa-miR-320b;hsa-miR-335-3p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-577;hsa-miR-592;hsa-miR-7-1-3p | 12 | CSNK1A1 | Sponge network | -2.298 | 0.00168 | -0.125 | 0.51313 | 0.256 |
62 | MEG3 |
hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-182-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-320b;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-3662;hsa-miR-429;hsa-miR-576-5p;hsa-miR-577;hsa-miR-96-5p | 18 | DAAM1 | Sponge network | -1.645 | 0.00049 | -0.57 | 0.03626 | 0.252 |